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ABSTRACT
Background: There is a continual need to evaluate and develop the ethical quality of scientific
research and to widen knowledge about the ethical aspects of informed consent. Informed
consent is ethically and legally required for health research involving human participants.
Therefore, there is a need to examine, according to the research participants, how well informed
consent has been realized in the research protocol in which they are participating.
Objective: The purpose of this study was to describe, analyze and evaluate the realization of
informed consent in lifestyle intervention study from the point of view of voluntary adult
participants.
Methods: In  the  first  phase,  the  questionnaire  was  created  and  tested  in  a  pilot  study.  In  the
primary study (second phase), the subjects were a random population sample of 1410 men and
women aged 57–78 years who are participating in a 4-year randomized controlled intervention
trial on the effects of physical exercise and diet on atherosclerosis, endothelial function and
cognition in the Kuopio Research Institute of Exercise Medicine. The questionnaire about
informed consent was given to all willing participants (n=1324) three months after the
randomization. This data were collected over a 23-month period in 2005–2007. The response
rate was 91 %. Data on implementation and success in the exercise and diet interventions were
evaluated at 12 months by the intervention-group personnel. This evaluation were done in a
subpopulation (n=597). The data were analyzed with statistical methods (descriptive statistics
and multivariate analyses).
Results: In this study, the key elements of informed consent were defined as information,
understanding, competence, voluntariness, and decision-making. The majority of the
participants estimated that information given in the exercise and diet intervention study was
adequate and in an intelligible form. The competence of the participants was judged to be
sufficient. The participants considered that the decision-making had been voluntary, and the
majority of them felt that confirmation and verification of informed consent were also carried
out well. About half of the participants had achieved good results in the intervention. Nearly
half of the participants had added to or improved their own activity in some sector of exercise or
diet. Significant associations were found between performance and success in the interventions
and participants’ knowledge of the purpose of the study.
Conclusions: This thesis adds knowledge about the realization of informed consent in health
research from the point of view of voluntary adult research participants. The findings of this
thesis indicated the importance of successful informed consent processes at an early stage of
trials. This study highlights the need for researchers to analyze critically the quality of
information and how it is provided. This is especially important in long-term follow-up studies.
Further study efforts should be focuced on understanding potential obstacles faced by research
participants knowledge in their understanding of the informed consent process.
National Library of Medicine Classification: W20.55.H9, W 50
Medical Subject Headings: Ethics; Informed Consent; Research; Research Subjects; Knowledge
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1  INTRODUCTION
The ethical acceptability of scientific research, trustworthiness and credibility of results
requires that the research should adhere to the principles of good scientific practice. In
research being carried out in humans, the main ethical questions are the participant’s
consent and his/her awareness of possible risks and harm compared with impending
benefit. (Tutkimuksen eettinen arviointi Suomessa 2006.) Therefore, research scientists
have an obligation to inform those whom they wish to participate in their research of the
rights that exist to enhance all aspects of human dignity. For example, protection of
identity, privacy, obtaining informed consent and communicating benefit and risk are
some of the most important ethical issues that researchers must address. It is self-
evident  that  researchers  should  commit  the  same  energy  and  enthusiasm  that  they
display for their scientific endeavours to ethics and scientific integrity. It should be the
case that ethics permeates every area of research. In fact, it has been stated that research
excellence can only be achieved by getting the ethics right. (Potocnik 2007.)
There is a need in basic and clinical research to develop the knowledge of health and
illness (e.g. Federman 2003, Johnston et al. 2006). In addition, clinical research is
necessary to establish the safety and effectiveness of specific health and medical
products and practices (World Health Organization, WHO 2002). None of these studies
would be possible without participation by willing human subjects (Dickert, Emanuel &
Grady 2002). Therefore, it is important to motivate people to participate in research
projects, since this is the only way to produce a reliable data base about public health
(Johnston et al. 2006). Research on ‘healthy’ voluntary participants needs to be
conducted in such a way that the highest ethical standards minimize the risks (Federman
2003, see also Steinbrook 2002). One of the main ethical principles is ‘informed
consent’.
Informed consent is required for all biomedical and health research involving human
participants (e.g. Beauchamp & Childress 2001). Informed consent means that each
potential subject must be adequately informed about the study in question; and after
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ensuring that the potential subject has understood the information, the researcher should
then obtain the subject’s freely-given informed consent (World Medical Association,
WMA 2004). This entails that the participant must have the formal competence to make
the decision in question (Syse 2000). Thus, at the centre of informed consent remains
the  critical  primacy  of  the  right  of  the  patient  or  participant  to  understand  the  given
information (Beckerman 2002). Therefore, only persons who are able to freely
understand and question, should consent. It does exclude vulnerable persons (i.e.
prisoners, mentally-deficient persons, severely-injured patients, very young children).
However, to avoid any loss of opportunities for these persons, there should be a legal
framework to guarantee their participation (notion of surrogate legal and therapeutic
representative). (European Commission 2007.)
In general, the purpose of health research is to improve people’s health and well-being.
For instance, declining physical activity is associated with a rising burden of global
disease (Kinmonth et al. 2008). It is often stated that prevention is better than cure and
thus lifestyle interventions are important topics for research. For example, the number
of individuals with diabetes is growing at an alarming rate. Prompt intervention by
promoting and facilitating improvements in diet, activity levels, and body weight is
hoped  not  only  to  result  in  prevention  of  diabetes,  but  also  to  achieve  overall
improvements in physical and mental health. (Weber & Narayan 2008, cf. Beswick et
al. 2008.) However, many efforts to reverse this trend have not been successful
(Kinmonth et al. 2008).
Achieving good health can be regarded as a basic human right. The purpose of ethics is
to find answers to questions examining good and correct ways to live and act in a world
that man shares with others. Ethics helps people make choices and analyzes the grounds
for their actions, without giving any ready-made, universally applicable solutions.
Concepts of good and bad, for instance, are rather global, but their emphases and
interpretations vary according to culture as well as with time. (ETENE 2001a, Pietilä &
Länsimies-Antikainen 2008, cf. Lääkärin etiikka 2005.)
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In nursing science, ethical questions are an important research topic (Eriksson et al.
2008). Therefore, there has been a recent upswing in interest in the ethics of research. In
addition, much has been written about the topic, most of it focusing on the protection of
vulnerable participants from harm. (Oberle & Allen 2006). However, more work is
needed into nursing ethics (Leino-Kilpi 2004, Spear 2007). Since, the nurse has an
advocacy role in patient care and is morally obligated to ensure that patient concerns are
heard (Oberle & Allen 2006). More extensive multidisciplinary research on the topic of
informed consent is also needed. It has been stated that many ethical questions in health
care are much easier to understand if investigated by a multidisciplinary team e.g.
consisting of nurse researchers, medical doctors, philosophers, sociologists and lawyers
(Leino-Kilpi 2004). This study was performed in a multidisciplinary group which
proved the value of this type of approach.
The focus of this thesis is on ethics and the viewpoint is in health sciences. The purpose
of this study was to describe, analyze and evaluate the realization of informed consent
in health research as expressed by voluntary adult research participants. In this context,
voluntary adult participant means that the person has no treatment connections with the
research institute or its researchers. Empirical studies from this point of view are still
exiguous (e.g. Rabin & Tabak 2006, Spear 2007). This is surprising since many clinical
trials are conducted e.g. in Finland and thus many volunteers are needed. In addition,
under the Sixth Framework Programme for Research (2002–2006), the European
Commission has taken the responsibility of ensuring that e.g. the ethical aspects are
taken into account at the earliest possible stage of Community-funded research in the
life sciences and biotechnology (European Commission 2008).
In this study, the emphasis was to acquire knowledge of true consent and one starting
point for this is to consider the formal requirements related to consent (effective
consent).  The  formal  requirement  in  this  study  was,  for  example,  the  provision  of
information to research participants (e.g. amount, quality). The significance of formal
requirements is to ensure that all possible participants are able to give genuine informed
consent. (Mäkelä 2007.) The working hypothesis of this study was that with sufficient
and understandable information one can ensure the satisfaction and engagement of the
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participants in the research project, while not forgetting safety. As a consequence, one
may  hope  that  the  participants  will  remain  in  the  project  and  as  few  as  possible  will
drop  out.  In  addition,  this  commitment  can  ensure  that  the  aims  of  the  project  are
achieved  and  the  results  are  as  reliable  as  possible.  The  participant  obtains  a  positive
experience in which case he or she may be willing to volunteer again in some other
project.
The  theoretical  framework  on  this  thesis  is  based  on  current  declarations,  regulations,
guidelines, and legislation. The key elements of informed consent are described from
relevant literature and scientific research. The theoretical framework is confirmed with
literature review which concentrated on recent empirical scientific research. This study
does not further discuss ethics as a philosophical viewpoint or contemplate ethics
theories.
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2  INFORMED CONSENT IN THE LITERATURE
Informed consent is one of the basic principles of research ethics. We are fortunate that
nowadays there are many trust-worthy and excellent open access websites which
include details of research ethics (i.e. American Medical Association [http://www.ama-
assn.org/ama/pub/category/2512.html], BioethicsWeb [http://www.bioethicsweb.ac.uk],
Council for International Organizations of Medical Sciences [http://www.cioms.ch/
guidelines_nov_2002_blurb.htm], European Commission [http://ec.europa.eu/research/
biosociety/bioethics/bioethics_en.htm], Finnish Medical Association [http://www.
laakariliitto.fi/e/ethics/], World Health Organization [http://www.who.int/topics/
ethics/en/], World Medical Association [http://www.wma.net/e]. Therefore, the purpose
of this chapter is not to review comprehensively the whole wide field of research ethics.
Instead, this chapter considers examples of how ‘informed consent’ is defined, the
background of informed consent, reviewing briefly its history, some declarations and
regulations, and also Finnish legislation as well as assessing the basic elements of
informed consent. At the end of this chapter, some recent research on the topic of
informed consent is reviewed. The same elements are repeated in different definitions,
regulations, declarations and legislation. Hence, there is some repetition and overlap in
this chapter. However, this highlights the wide consensus of informed consent as an
ethical principle.
2.1  Definitions of informed consent
Informed consent means that the patient or study participant is given sufficient and
understandable information to enable independent decision-making (Declaration of
Helsinki 2008). The philosophical basis of valid consent rests on the principle of patient
or participant autonomy. Before one can have valid consent, the physician, researcher
etc. must disclose information to the patient or potential participant who is competent
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and then the patient or participant should be able to understand the information and
make a voluntary decision. (Hope 2005.)
In the dictionary, the word ‘informed’ (adjective) means: 1a) possessing information, b)
based on possession of information; 2) knowledgeable about matters of contemporary
interest; educated (Longman Group Limited 1984). 3) Instructed; having knowledge of
or acquaintance with facts; educated, enlightened, intelligent (Oxford English
Dictionary Online 2009). ‘Consent’ (verb intransitive) means: 1) to give assent or
approval; agree to; 2) archaic to be in agreement in opinion or feeling. ’Consent’ (noun)
means: 1) agreement to or approval of what is done or proposed by another;
acquiescence; 2) agreement as to action or opinion. (Longman Group Limited 1984.) 3)
Voluntary agreement to or acquiescence in what another proposes or desires;
compliance, concurrence, permission (Oxford English Dictionary Online 2009).
In the dictionary, the phrase ‘informed consent’ (noun) means: Law permission granted
in the knowledge of the possible consequences; (Med.) consent to clinical treatment
given after all relevant information (especially regarding potential risks and benefits)
has been disclosed to the patient or the patient’s guardian; an instance of such consent.
(Oxford English Dictionary Online 2009). Table 1 gives some examples of the different
definitions of informed consent that have been employed.
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Table 1 Some definitions of informed consent
Author/-s Definition
Fry
1998
Informed consent means that the patient or study subject is given
sufficient and understandable information to enable independent
decision-making. Informed consent is a process that protects the
autonomy of research subjects, protects them from harm, and assists
scientists in avoiding fraud and coercion in their role of researcher.
Beauchamp &
Childress
2001
An informed consent is an individual’s autonomous authorization of
a medical intervention or of participation in research. A person must
do more than express agreement or comply with a proposal. He or
she must authorize something through an act of informed and
voluntary consent. An informed consent occurs if and only if a
patient or subject, with substantial understanding and in absence of
substantial control by others, intentionally authorizes a professional
to do something.
Beckerman
2002
Informed consent is a process between physician and patient that
must contain an information component and a consent component.
The information component refers to the disclosure of information
and comprehension of what is disclosed. The consent component
refers to a voluntary decision and agreement to undergo a
recommended procedure.
ICH – GCP
CPMP/ICH/135/95
2002
A process by which a subject voluntarily confirms his or her
willingness to participate in a particular trial, after having been
informed of all aspects of the trial that are relevant to the subject’s
decision to participate. Informed consent is documented by means of
a written, signed and dated informed consent form.
WMA
2004
Informed consent means that each potential subject must be
adequately informed about the study in question; and after ensuring
that the potential subject has understood the information, the
researcher should then obtain the subject’s freely-given informed
consent.
Turner
2005
Informed consent is the process by which a potential subject or a
legal representative is given explanations about the purpose of the
research and the risks, inconveniences, costs, potential benefits, and
right to withdraw from the study without repercussions. This must
occur prior to obtaining written or verbal consent for enrolment.
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In  conclusion,  informed  consent  can  be  defined  as  follows:  Informed  consent  is  a
process by which a potential participant is given sufficient and understandable
information about the study. After ensuring that the participant has understood this
information, the researcher obtains the participant’s freely-given written informed
consent. This previously described process enable participant’s independent decision-
making.
2.2  Short history of informed consent
An article by Vollmann and Winau (1996) gives overview of the dark history of
informed consent. This treatise exposes the following facts: The Nuremberg code of
1947 is generally regarded as the first document to set out ethical regulations in human
experimentations based on informed consent. However, recent research indicates that
ethical issues of informed consent in guidelines for human experimentations were
recognized as early as the nineteenth century. For example, in 1891, the Prussian
minister of the interior issued a directive to all prisons that tuberculin for the treatment
of tuberculosis ‘must in no case be used against the patient’s will’. However, in 1898
Albert Neisser (discoverer of the gonococcus and professor of dermatology and
venereology) published clinical trials on serum therapy in patients with syphilis. He had
injected cell free serum from patients with syphilis into patients who were admitted for
other medical conditions. Most of these patients were prostitutes, who were neither
informed about the experiment nor asked for their consent. (Vollmann & Winau 1996.)
Critical press reports and debate in parliament forced the Prussian government to issue
the first directive concerned with medical experimentation in humans in 1900. This
directive was based on medical and legal scientific reports. Nonetheless, these
regulations were not initiated by the medical profession but were issued after critical
public discussion and political debate. A clear distinction was made between therapeutic
and non-therapeutic research, but regulations were issued only for non-therapeutic
research. The regulations were based on the principle of autonomy and represented an
early model of informed consent. A ‘proper explanation of the possible negative
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consequences’ of the intervention and ‘unambiguous consent’ became the mandatory
standard. Minors and incompetent subjects were generally excluded from non-
therapeutic research, as they could not give valid informed consent. However, these
early regulations were not binding in the legal sense and little is known about their
actual impact on clinical research. (Vollmann & Winau 1996.)
Most academic physicians at the time supported Neisser. An exception was Albert Moll
(a psychiatrist in private practice in Berlin) who collected 600 cases of unethical non-
therapeutic research on humans and emphasized the need for informed consent. (Moll
1902, Vollmann & Winau 1996.) In addition, between 1930 and 1945, Japan conducted
human experimentation in biological warfare, including physical responses to infection
and trauma, and thousands were killed (Beckerman 2002).
Previously, in 1916, the Harvard physician Walter Cannon had recommended to the
House of Delegates of the American Medical Association that it should endorse the
importance of obtaining patient consent and cooperation in human experimentation. His
proposal, however, was not brought up for consideration. One influential physician
observed that it would open the way for a discussion of the importance of obtaining the
consent of the patient before any investigations were carried out which were not
primarily for the welfare of the patient. (Human & Fluss 2001.)
The phenomenon of informed consent was formally defined in the first principle of the
Nuremberg Code (Burns & Grove 2001). The Nuremberg Code in 1947 was adopted in
response  to  the  human  rights  atrocities  occurring  in  Nazi  concentration  camps.  The
major impetus for increased attention to the issues of informed consent was a series of
studies involving unethical actions on the part of researchers toward their participants.
These studies involved human rights violations in which participants were neither
informed nor had the possibility to refuse participation. (Turner 1998.)
In  the  Nuremberg  war  trials,  it  was  revealed  that  physicians  (e.g.  Dr.  Josef  Mengele)
conducted abhorrent medical experiments on concentration camp prisoners. This
research included human experimentation with germ warfare, freezing individuals to
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learn what temperature would kill a person most effectively, and many more horrific
trials. The Nuremberg Code, which emerged from the trials, abandoned the earlier
paternalistic perspective of medicine and research and replaced it with the centrality of
patient self-determination by asserting that for medical research, the voluntary consent
of the human subject was necessary under all circumstances. (Beckerman 2002.)
Consequently,  since  the  Nuremberg  trials,  consent  has  been  at  the  forefront  of
biomedical ethics. The term ‘informed consent’ did not appear until a decade after these
trials (held in the late 1940s), and it was not examined in detail until the early 1970s
(Beauchamp & Childress 2001). The Nuremberg Code was followed by the Declaration
of Helsinki, adopted by the WMA in 1964 (Turner 2005).
2.3  Some regulations of informed consent
Due to the dark history of previous medical research, international declarations and
conventions have laid down ethical principles for medical research. They emphasize the
autonomy of the research participant, or his or her legal representative, so that he or she
can give a free and informed consent prior to the initiation of research. (Halila 2007.)
Thus, the notion of voluntary participation in research involving human subjects was
enunciated for the first time in the Nuremberg Code. Subsequently, several international
declarations sanctioned this concept as being pivotal in research ethics. (European
Commission 2007.) Some examples of these declarations are: Declaration of Helsinki
by WMA, International Ethical Guidelines for Biomedical Research Involving Human
Subjects (CIOMS 1993, last updated in 2002, www.cioms.ch) and Universal
Declaration on Bioethics and Human Rights adopted by UNESCO (UNESCO’s General
Conference on 19 October 2005, www.unesco.org).
All international declarations stipulate that, prior to consent, each participant in a
research project should be clearly informed of its goals, its possible adverse events, and
the  possibility  to  refuse  to  enter  or  to  retract  his/her  consent  at  any  time  with  no
repercussions. Moreover, no inducement should justify the participation in a research.
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(European Commission 2007.) In this thesis, some of the declarations or regulations are
examined in detail as examples.
Globalisation of research will demand better implementation of international ethical
guidelines. This is particularly true in areas like health research. (Potocnic 2007.) The
European  Commission,  for  instance,  has  begun  to  work  more  closely  also  with
developing countries to establish high ethical standards for research on a global basis
(Watson 2007).
2.3.1 Nuremberg Code
The Nuremberg code (1947, 2007) includes principles such as informed consent and
absence of coercion; properly formulated scientific experimentation; and beneficence
towards experiment participants. This code includes ten points. The first point is: The
voluntary consent of the human subject is absolutely essential. This means that the
person involved should have the legal capability to give consent; should be so situated
as to be able to exercise free power of choice, without the intervention of any element of
force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or
coercion; and should have sufficient knowledge and comprehension of the elements of
the subject matter involved as to enable him/her to make an understanding and
enlightened decision.
This latter element requires that before the acceptance of an affirmative decision by the
experimental subject there should be made known to him/her the nature, duration, and
purpose of the experiment; the method and means by which it is to be conducted; all
inconveniences and hazards reasonable to be expected; and the effects upon his/her
health which may possibly result from participation in the experiment. The duty and
responsibility for ascertaining the quality of the consent rests upon each individual who
initiates, directs or engages in the experiment. It is a personal duty and responsibility
which may not be delegated to another with impunity. (Nuremberg Code 1947, 2007.)
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2.3.2 Declaration of Helsinki
The Declaration of Helsinki was adopted by the 18th World Medical Association
(WMA) General Assembly at June 1964 in Helsinki, Finland, and has been amended
eight times (in 1975, 1983, 1989, 1996, 2000, 2002, 2004 and 2008). The WMA has
developed  the  Declaration  of  Helsinki  as  a  statement  of  ethical  principles  to  provide
guidance for physicians and other participants in medical research involving human
subjects, including research on identifiable human material or identifiable data (Point
1). Although the Declaration was addressed primarily to physicians, the WMA has
encouraged other participants in medical research involving human subjects to adopt
these principles (Point 2). (Declaration of Helsinki 2008.) In table 2 is presented some
more points from the Declaration. These points are directly connected with informed
consent.
29
Table 2 Quotations of Declaration of Helsinki
Relevant portions of Declaration of Helsinki (2008)
Point 24 In medical research involving competent human subjects, each potential participant
must be adequately informed about the aims, methods, sources of funding, any possible
conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and
potential risks of the study and any discomfort it may entail, and any other relevant aspects of
the study. The potential subject must be informed of the right to refuse to participate in the
study or to withdraw consent to participate at any time without reprisal. Special attention
should be given to the specific information needs of individual potential subjects as well as to
the methods used to deliver the information. After ensuring that the potential subject has
understood the information, the physician or another appropriately qualified individual must
then seek the potential subject’s freely-given informed consent, preferably in writing. If
consent cannot be obtained in writing, the non-written consent must be formally documented
and witnessed.
Point 26 When seeking informed consent for participation in a research study, the physician
should be particularly cautious if the potential subject is in a dependent relationship with the
physician or may consent under duress. In such situations, the informed consent should be
sought by an appropriately qualified individual who is completely independent of this
relationship.
Point 27 For a potential research subject who is incompetent, the physician must seek informed
consent from the legally authorized representative. These individuals must not be included in a
research study that has no likelihood of benefit for them unless it is intended to promote the
health of the population represented by the potential subject, the research cannot instead be
performed with competent persons, and the research entails only minimal risk and minimal
burden.
Point 28 When a potential research subject who is deemed incompetent is able to give assent to
decisions about participation in research, the physician must seek that assent in addition to the
consent of the legally authorized representative. The potential subject’s dissent should be
respected.
Point 29 Research involving subjects who are physically or mentally incapable of giving
consent, for example, unconscious patients, may be done only if the physical or mental
condition that prevents giving informed consent is a necessary characteristic of the research
population. In such circumstances, the physician should seek informed consent from the legally
authorized representative. If no such representative is available and if the research cannot be
delayed, the study may proceed without informed consent provided that the specific reasons for
involving subjects with a condition that renders them unable to give informed consent have
been stated in the research protocol and the study has been approved by a research ethics
committee. Consent to remain in the research should be obtained as soon as possible from the
subject or a legally authorized representative.
Point 34 The physician must  fully inform the patient  which aspects  of  the care are  related to
the  research.  The  refusal  of  a  patient  to  participate  in  a  study  or  the  patient’s  decision  to
withdraw from the study must never interfere with the patient-physician relationship.
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2.3.3 Universal Declaration on Bioethics and Human Rights
In October 2005, the General Conference of UNESCO adopted by acclamation the
Universal Declaration on Bioethics and Human Rights. It deals with ethical issues
arising in medicine, life sciences and associated technologies as applied to human
beings. The Declaration is based on the principles it endorses in the rules that govern
respect for human dignity, human rights and fundamental freedoms.
This  declaration  has  15  principles  (Article  3  –  Article  17).  For  example,  Article  6
discusses consent as follows: “Any preventive, diagnostic and therapeutic medical
intervention is only to be carried out with the prior, free and informed consent of the
person concerned, based on adequate information. The consent should, where
appropriate, be expressed and may be withdrawn by the person concerned at any time
and for any reason without disadvantage or prejudice. Scientific research should only be
carried out with the prior, free, expressed and informed consent of the person
concerned. The information should be adequate, provided in a comprehensible form and
should include modalities for withdrawal of consent. Consent may be withdrawn by the
person concerned at any time and for any reason without any disadvantages or
prejudice.” (UNESCO 2005.)
2.3.4 Good Clinical Practice (GCP)
The WHO has developed guidelines for Good Clinical Practice (in 1994) for trials of
pharmaceutical products in order to establish globally applicable standards for the
conduct of biomedical research on human subjects. The guidelines protect the rights and
safety of subjects, including patients, and they ensure that the investigations are directed
to the advancement of public health objectives. (Idänpää-Heikkilä 1994.)
In 2002, WHO published ‘Handbook for good clinical research practice (GCP):
guidance for implementation’. This handbook states that good clinical research practice
is a process that incorporates established ethical and scientific quality standards for the
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design, conduct, recording and reporting of clinical research involving the participation
of human subjects. Compliance with GCP provides public assurance that the rights,
safety, and well-being of research subjects are protected and respected, consistent with
the principles enunciated in the Declaration of Helsinki and other internationally
recognized ethical guidelines, and ensures the integrity of clinical research data.
Informed consent is defined in this guideline as Principle 7: “Freely given informed
consent should be obtained from every subject prior to research participation in
accordance with national culture(s) and requirements. When a subject is not capable of
giving informed consent, the permission of a legally authorized representative should be
obtained in accordance with applicable law.” (WHO 2002.)
International Conference on Harmonisation of technical requirements for registration of
pharmaceuticals for human use – Good Clinical Practice (ICH–GCP), in 1996, is also an
international ethical and scientific quality standard for designing, conducting, recording
and reporting trials that involve the participation of human subjects. Compliance with
this standard provides public assurance that the rights, safety and well-being of trial
subjects are protected, consistent with the principles that have their origin in the
Declaration of Helsinki, and that the clinical trial data are credible.
The objective of ICH–GCP guidelines is to provide a unified standard for the European
Union (EU), Japan and the United States to facilitate the mutual acceptance of clinical
data by the regulatory authorities in these jurisdictions. The guideline was developed
with  consideration  of  the  current  good  clinical  practices  of  the  EU,  Japan,  and  the
United States, as well as those of Australia, Canada, the Nordic countries and the WHO.
Informed consent is also defined in this guideline (see table 1). (ICH–GCP.)
2.3.5 Finnish Medical Associations code of medical ethics
The Delegate Committee of the Finnish Medical Association has adopted (in May 1988)
a code of medical ethics to be observed by physicians in their profession. In its fourth
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point  it  states:  “A  physician  shall  not  use  his  (sic)  authority  to  undermine  a  patient’s
right to make decisions concerning himself (sic). Even where the patient cannot convey
his (sic) own will, it is incumbent upon the physician to act in the patient’s best interest.
If a physician is compelled to make decisions concerning examinations or therapy
irrespective of the patient’s will, such decisions shall always be made on medical
grounds.” (Finnish Medical Association 2007.)
The Sixth point discuss patient’s participation in medical research: “Should a physician
wish for his (sic) patient to participate in a clinical trial in which the examinations and
therapy deviate from the normal procedure for the disease, he (sic) shall obtain the
patient’s freely-given consent without pressure, the patient being aware of the trial and
of the additional strain and risks involved. Generally accepted declarations and
instructions issued by the authorities shall be observed during the trial.” (Finnish
Medical Association 2007.)
2.4  Finnish legislation concerning informed consent
Finnish national legislation does take into account research ethics and the protection of
individual rights in health care. First, there are several laws and decrees relating to this
field. The most important laws concerning informed consent in Finland are: ‘Medical
Research Act’ and ‘Act on the Status and Rights of Patients’. It is noteworthy that
Finland was the first country to issue an Act on the Status and Rights of Patients in
1992, and one of the first countries to issue an Act on Medical Research in 1999 (Halila
2003). An extensive list and link of laws and decrees can be found, for example, at the
local ethical committee website (Kuopio University Hospital > Scientific research >
Ethical committee [http://www.psshp.fi/index.asp?tz=-2]).
Second, there are several national ethics commissions in Finland. The National
Advisory Board on Research Ethics was first established in 1991. The National
Advisory Board on Health Care Ethics was established in 1998, followed by its Sub-
Committee on Medical Research Ethics in 1999. This sub-committee acts as a national
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research ethics committee and provides opinions about research projects. The National
Advisory Board on Research Ethics can promote legislation by making proposals and
statements to the ministries and the government. It acts as an expert body on research
ethics, promotes discussion, and takes initiatives in advancing research ethics. It also
collects  and  shares  information  about  research  ethics.  The  Board  has  an  advisory  role
and does not issue legally binding decisions, although while resolving cases of
misconduct and fraud in science, the recommendations that the Board makes are highly
respected. (Halila 2003.)
The law often represents the lowest level of acceptable behaviour. Therefore, it has been
stated that it is important that law and ethics should not totally coalesce, lest ethics
vanish altogether and furthermore, clinicians and researchers should surely be striving
for higher standards than the bare minimum. (Sokol 2008.)
2.4.1 Medical Research Act
This law (No. 488/1999) applies to medical research carried out on persons, human
embryos and human foetuses, unless otherwise provided by legislation. It was enacted
on April 1999 (amended No. 294/2004).
Chapter 2, section 6 covers consent of research subjects. In this section it is stated:
“Medical research on persons may not be conducted without the research subject’s
informed consent in writing. Exceptions to this may be made where consent cannot be
obtained  owing  to  the  urgency  of  the  matter  and  the  patient’s  state  of  health  and  the
measure is expected to be of immediate benefit to the patient’s health. If the research
subject is not able to write, he or she can give the consent orally in the presence of at
least one witness who is independent of the research. Research subjects shall have their
rights, the purpose and nature of the research and the procedures it involves properly
explained to them. The potential risks and harm shall also be properly explained to
them. This information shall be given so that research subjects are in a position to give
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their informed consent with regard to issues connected with the research that has a
bearing on their decision-making.”
Furthermore, the Act states that research subjects shall be entitled to withdraw their
consent at any point prior to the completion of the research. They shall be informed of
this  right  before  the  start  of  the  research.  Withdrawal  of  consent  and  resulting
withdrawal from the research shall not involve any negative consequences for the
subject.
Chapter 2, section 7 is concerned with research involving persons not able to provide
consent: “People who, owing to a mental health disorder, retardation or other similar
reason, do not have the capacity to give their consent to research may be research
subjects only where it is not possible to obtain the same scientific results using other
research subjects and where the risk of harming or distressing the research subject is
only  very  slight.  It  is  a  further  stipulation  that  the  research  should  be  likely  to  be  of
direct benefit to the research subject’s health; or the research should be likely to be of
special benefit to the health of people in the same age group or with the same state of
health.”
Section 8 is devoted to research involving minors. The content of section 8 is very
similar to section 7. In addition, it states: “Where the minor has reached the age of 15
and, in view of his/her age and maturity and the type of illness and research, is capable
of understanding the importance of the research procedure and the research is likely to
be confer a benefit on the minor’s health, it shall be sufficient for the minor to give
his/her informed consent in writing. In such cases, the guardian shall be informed of
this. In other cases, minors may be research subjects only where written consent for this
has been given by their guardian or legal representative after being provided with the
information referred to in section 6. The consent must be in accordance with the minor’s
supposed will. Where a minor opposes a research or a research measure, the minor’s
opinion shall be complied with, taking account of his/her age and maturity.”
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Section 9 is concerned with research involving pregnant women and nursing mothers:
2Pregnant women and nursing mothers may be research subjects only where it is not
possible to obtain the same scientific results using other research subjects and the
research is likely to be of direct benefit to the health of the woman or the unborn child;
or the research is likely to be of benefit to the health of people related to the woman, or
to pregnant woman or nursing mothers, or to foetuses, newborn children or unweaned
children.”
Furthermore, section 10 is devoted to research involving prisoners. It states that
prisoners may be research subjects only where the research is likely to be of direct
benefit to their own health or the health of people related to them or the health of other
prisoners. (Laki lääketieteellisestä tutkimuksesta 1999, Medical Research Act 1999.)
2.4.2 Medical Research Decree
The medical research decree (No. 986/1999) entered into force on November 1999
(amended No. 313/2004). Section 3 is the part of the document related to provision of
consent. It states that the document of consent shall include the following: the research
subject’s name, personal identity code or date of birth, and address; that the information
has been given to the research subject and data about the giver of the information;
which other sources, information concerning the research subject will be gathered from;
whom the  information  gathered  in  the  context  of  the  research  can  be  delivered  to  and
how the confidentiality of the information is protected; the research subject’s voluntary
consent; and mention of the right to withdraw the consent without it affecting the
research subject’s right to receive the care he/she is in need of.
The document of consent shall be dated, and it shall be signed by both the person who
gives and the person who receives the consent. A copy of document shall be given to
the giver of the consent. If the research subject has given the consent orally because he
or she is not able to write, a witness independent of the research shall sign the document
of consent. The witness’ signature shall be appended with clarification of the name and
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contact information. (Asetus lääketieteellisestä tutkimuksesta 1999, Medical Research
Decree 1999, Asetus lääketieteellisestä tutkimuksesta annetun asetuksen muuttamisesta
2004.)
2.4.3 Act on the status and rights of patients
This act on the status and rights of patients (No. 785/1992) was issued on August 1992.
Chapter 2 defines the rights of patients. The patient’s right to be informed is defined in
section 5 as follows: “A patient shall be given information about his/her state of health,
the significance of the treatment, various alternative forms of treatment and their effects
as well as information about other factors related to his/her treatment that are significant
when decisions are made on the treatment given to him/her. However, this information
shall not be given against the will of the patient or when it is obvious that providing the
information would represent a serious hazard to the life or health of the patient. Health
care professionals should try to give the information in such a way that the patient can
understand it. If the health care professional does not know the language used by the
patient or if the patient because of a sensory handicap or speech defect cannot be
understood, interpretation should be provided if possible.”
Section 6 (chapter 2) defines the patients’ right to self-determination. This means that
the patient has to be cared with approval. If the patient refuses a certain treatment or
measure, he/she has to receive care, as far as possible, some other medically acceptable
way to which he/she approves. (Laki potilaan asemasta ja oikeuksista 1992, Act on the
status and rights of patients 1992.)
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2.5  Key elements of informed consent
In  this  study,  the  key  elements  of  informed  consent  were  defined  as  follows:
information, understanding, competence, voluntariness, and decision-making
(Beauchamp & Childress 2001, Leino-Kilpi et al. 2002). The basic elements of
informed consent are information, understanding and decision-making. Competence is a
fundamental factor in the reception and understanding of information and for making an
independent and voluntary decision about participation. This definition is based on the
early literature (including regulations etc.) and on a pilot study (Original publication I).
The key elements are described in various ways in the literature. However, the same
elements are repeated. Table 3 presents some different descriptions.
Table 3 Key elements of informed consent
Author/-s Definition of elements
Beauchamp &
Childress
2001
The elements of informed consent are threshold (preconditions),
information and consent. Threshold elements are: competence (to
understand and decide) and voluntariness (in deciding). Information
elements are: disclosure (of material information), recommendation
(of a plan) and understanding (of disclosure and recommendation).
Consent elements are: decision (in favour of a plan) and authorisation
(of the chosen plan).
Beckerman
2002
The informed consent is viable if the person is competent to act,
receives thorough disclosure, has an understanding, and is voluntary
in his or her consent. For informed consent to be legally recognized,
the following steps need to be clearly articulated: Preconditions,
which includes competence (to understand and to decide) and
voluntariness (in deciding). Information element, which includes
disclosure (of risk/benefits), recommendations (plan) and
understanding (of information and plan). Consent elements, which
include authorization (based on patient autonomy).
Burns & Grove
2001
Informed consent consists of four elements: disclosure of essential
information, comprehension, competency and voluntarism.
Leino-Kilpi et al.
2002
Informed consent has three basic dimensions: prerequisites, decision-
making activities and the outcomes of decision-making. The
prerequisites are information, competence, understanding,
willingness, voluntariness and lack of coercion. The consequences of
decision-making activities are consent, acceptance or rejection.
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Although different definitions of key element of informed consent are presented, there
is a consensus that information is the most essential element. Therefore, several
institutions have made lists of the topics needed to be mentioned in the informed
consent process. For example, according to the European Commission (2007), research
participants should be provided with the information presented in table 4 before they
participate in a study.
Table  4 Information to be provided to research participants according to the European
Commission
List of information
A statement that the study involves research subjects, an explanation of the purposes of the
research and the expected duration of the subject’s participation, a description of the
procedures to be followed, and identification of any procedures which are experimental.
A description of any reasonably foreseeable risks or discomforts to the subject.
A description of any benefits to the subject or to others which may reasonably be expected
from the research.
Insurance guarantees provided to participants.
For research involving more than minimal risk, an explanation as to whether there are any
treatments or compensation if injury occurs and, if so, what they consist of, or where further
information may be obtained.
A disclosure of appropriate procedures in case of incidental findings.
A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be
advantageous to the subject.
A statement describing the extent, if any, to which confidentiality of records identifying the
subject will be maintained.
An explanation of whom to contact at any time for answers to pertinent questions about the
research and research subject’s rights, and whom to contact in the event of a research-related
injury to the subject.
A statement that participation is voluntary, refusal to participate will involve no penalty or loss
of benefits to which the subject is otherwise entitled, and the subject may discontinue
participation at any time without penalty.
(European Commission 2007)
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International Ethical Guidelines for Biomedical Research Involving Human Subjects
(CIOMS 2002) defines the essential information for prospective research subjects with a
26 point list. Some examples of the salient matters on this list are: That the individual is
invited to participate in research, the reason for considering the individual suitable for
the research, and that participation is voluntary. That the individual is free to refuse to
participate and will be free to withdraw from the research at any time without penalty or
loss of benefits to which he or she would otherwise be entitled. The purpose of the
research, the procedures to be carried out by the investigator and the subject, and an
explanation of how the research differs from routine medical care. The expected
duration of the individual’s participation (including number and duration of visits to the
research centre and the total time involved) and the possibility of early termination of
the trial or of the individual’s participation in it. (CIOMS 2002.)
In addition, the essential information includes: Whether money or other forms of
material goods will be provided in return for the individual’s participation and, if so, the
kind and amount. That, after the completion of the study, subjects will be informed of
the findings of the research in general, and individual subjects will be informed of any
finding  that  relates  to  their  particular  health  status.  Any  foreseeable  risks,  pain  or
discomfort, or inconvenience to the individual (or others) associated with participation
in the research, including risks to the health or well-being of a subject’s spouse or
partner. The direct benefits, if any, expected to result to subjects from participating in
the research. The expected benefits of the research to the community or to society at
large,  or  contributions  to  scientific  knowledge.  And  that  an  ethical  review  committee
has approved or cleared the research protocol. (CIOMS 2002.)
The  Ministry  of  Social  Affairs  and  Health,  National  Advisory  Board  on  Health  Care
Ethics (ETENE) sub-committee on Medical Research Ethics (TUKIJA) has devised
(2001, updated at April 2009) also a checklist for researchers and members of ethics
committees (ETENE 2001b). In this list, the fourth point discusses the information to be
given the research subject. This elaborates, for example, that the information to research
subjects should include all the essential information on the research that the subjects
need to be able to give their informed consent. A good information sheet is short,
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matter-of-fact and understandable. The information should be given personally to each
research subject both orally and in writing. All research subjects must be provided with
an opportunity for asking questions. The written information should include, above all,
the following: facts about the research; voluntariness of participation and withdrawal of
consent; impacts of participation to research; data protection, costs, remuneration,
insurance; treatment after the research.
In addition, the information sheet should be written using easily understandable
language, and the research subject should be provided with sufficient time to familiarize
him/herself with its contents. Unless the research subjects are clearly restricted to either
Finnish or Swedish speaking persons, the information must be available in both
languages. If there are persons in the sample who do not understand either of the
domestic languages, the information sheet must be available in the language that the
research subjects understand well. The standard of language should correspond to the
language used by the subject group. For example, there may be a specific information
sheet for children or persons suffering from dementia in addition to the possible
information to their representatives. (ETENE 2001b.)
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2.6  Literature review of recent research
2.6.1 Data retrieval
This literature review is based on a systematic review on MEDLINE (PubMed),
Cochrane and Medic databases at January 2009. An extensive number articles
concerning informed consent have been published internationally. For example, a search
of the Cochrane Library with the phrase “informed consent” resulted without limits:
Cochrane reviews 5546, other reviews 9025, clinical trials 549 336, method studies
10 973, technology assessments 7528 and economic evaluations 24 451. Therefore, the
review was limited to 1) MEDLINE (PubMed) as follows: a) published in the last 10
years, b) only items with abstracts, c) type of publication: clinical trials, meta-analysis,
practice guideline, randomized controlled trial, review, classical article, d) language:
English, e) age: all adult: 19+ years. Limit in 2) Cochrane Library was: a) published
2000–2009 and b) keywords. And limit in 3) Medic was: published 2000–2009.
Searches were done with several words and combinations but the final search words in
MEDLINE (PubMed) were: “informed consent AND participant”, “informed consent
AND subject”, “informed consent AND intervention study”, “informed consent AND
health survey, “informed consent AND information”, “informed consent AND
understanding”, “informed consent AND competence”, “informed consent AND
voluntariness” and “informed consent AND decision-making”. The search word in
Cochrane was: “informed consent” and in Medic: “informed consent”, “tietoon
perustuva suostumus” and “tietoinen suostumus”.
A search with limits mentioned above, resulted in a MEDLINE (PubMed) total of 502
articles, a Cochrane total of 268 articles and a Medic total of 39 hits. The first selection
of articles (n=222) was made by title and the stipulation was that the title contained one
or more of the following words: ‘informed consent’, research or trial or study etc.,
participant or subject or volunteer etc., information, understanding, competence,
voluntariness or decision-making. The second selection was done from abstracts and
limited so that the same article was not found from some other database. After deleting
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duplications, the number of abstracts was 136. Finally, after reading the abstracts, the
remaining  amount  of  printed  full  text  articles  was  49.  The  data  retrieval  and  selection
process is presented in detail in table 5.
Table 5 The data retrieval (at January 2009) and selection process
Database Words Amount First
selection
(title)
Second
selection
(abstract +
overlapping
deleted)
Final
selection
(full text)
MEDLINE
(PubMed)
“ic + participant”
“ic + subject”
“ic + intervention study”
“ic + health survey”
“ic + information”
“ic + understanding”
“ic + competence”
“ic + voluntariness”
“ic + decision-making”
28
41
4
5
170
74
78
5
97
12
12
0
1
40
28
24
2
28
12
11
0
1
34
11
14
1
9
5
2
0
0
16
5
3
0
1
Total 502 147 93 32
Cochrane “ic” at Cochrane reviews
“ic” at Other reviews
“ic” at Clinical trials
“ic” at Method studies
“ic” at Technology
assessments
“ic” at Economic
evaluations
2
5
252
1
1
7
1
2
70
1
0
1
1
2
39
1
0
0
1
2
14
0
0
0
Total 268 75 43 17
Medic “informed consent,
tietoon perustuva
suostumus, tietoinen
suostumus” 39 0 0 0
Total 809 222 136 49
ic = informed consent
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This described data retrieval and selection process excluded results from national
literature search of Medic database. However, there have been relevant studies and other
reports about informed consent and reviews about research ethics published in this
decade in Finland. For example, the above-mentioned national literature search (at
January 2009) with phrase ‘informed consent’ (in English and in Finnish) between years
2000–2009 resulted in 39 search hit. A search of the same database with different
combinations of words research and ethics (in Finnish) resulted in 99 hits. However,
Välimäki and co-workers (2000) published an overview of academic theses concerning
nursing ethics in Finland between the years 1984–1997. There have been 89 theses
published in the topic of nursing ethics which accounts for 6.8 % of all published
academic nursing theses. Välimäki and co-workers concluded that research on ethics
was not common in academic thesis in Finland during that time period. Therefore, the
present situation leads to the assumption that interest in ethical topics has increased.
In this context it is a pleasure to mention some examples of recent Finnish doctoral
dissertations concerning ethics: Behm (2008) questioned the argument that the moral
personality of scientists explains ethical problems in science; in addition, the focus was
shifted from individuals to the level of the research environment (Research norms and
norms of the research environment). Kanerva (2006) analyzed and compared the
perceptions of day surgery patients and nurses and doctors about the realization of
informed consent in a day surgery patient’s care and the perceptions of patients and
nurses about a nurse’s responsibilities (Informed consent in a day surgery patient’s care
– analysis of the realisation of informed consent and a nurse’s implication). Lötjönen
(2004) examined the national and international sources of law that are concerned with
medical research and addressed the relevance of ethical codes (Medical research on
humans – legal and ethical aspects on encroaching physical integrity in medical
research). Nyrhinen (2007) identified ethical issues in diagnostic genetic testing and
described, compared and explained the realization of ethical principles, autonomy,
privacy, equality and benefits in diagnostic genetic testing (Ethics in diagnostic genetic
testing).
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In addition, the data retrieval and selection process excluded, for example, articles that
dealt with everyday nursing. However, in the final two decades of the 20th century, an
explosion of nursing knowledge has guided practice and advanced the health and well-
being of individual clients, families, and communities (Hinshaw 2000). In addition, it is
noteworthy that the largest group of health care professionals in Europe is represented
by nurses (Leino-Kilpi et al. 2002). Nurses are responsible for well-being and quality of
life of many people, and therefore their profession requires high standards of technical
and ethical competence (Tadd et al. 2006). One notable research from this viewpoint is
the project on ‘Patient’s autonomy, privacy and informed consent in nursing
interventions’. This study focused on three different groups (in five European
countries): mothers with infants or babies in postnatal wards, surgical patients in
hospital wards, and long-term elderly patients in institutions. (Leino-Kilpi et al. 2002,
Leino-Kilpi et al. 2003a, Leino-Kilpi et al. 2003b, Schopp et al. 2003, Scott et al. 2003.)
2.6.2 Results of literature review
It has been stated that a great deal of e.g. bioethical literature focuses on the way the
individual can be protected in the medical context, for example in relation to research
(Nuffield Council of Bioethics 2007). However, the literature review of this thesis
reveals that there is a considerable amount of research on the topic of ‘informed
consent’ from the viewpoint of patient and different treatments or therapies (e.g.
patient’s approval to proposed treatment, patient’s selection between alternative
treatments or patient’s competence to make decisions concerning his/her treatment).
There are clearly fewer studies on the topic of informed consent to research.
Furthermore, there are even fewer investigations on this same topic but from the point
of view of voluntary adult research participants. The literature review of this thesis
focused on these two last mentioned groups.
All the reviewed studies are tabulated in detail in Appendix 1. In summary, nearly all
(n=45) of the reviewed studies were empirical and only four of them were systematic
reviews. These reviews focused on participants’ comprehension of informed consent in
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clinical trials (Cohn & Larson 2007), measures of decisional capacity for research and
treatment (Dunn et al. 2006), effectiveness of leaflets in promoting informed choice in
screening (Fox 2006), and effects of different methods of information provision to
potential clinical trials participants in informed consent process (Ryan et al. 2008).
In the empirical studies, the main method in use was a questionnaire survey or
questionnaire-based interview. The majority of studies used a self-administered
questionnaire  to  assess  different  components  of  informed  consent.  However,  some  of
the studies used a standardized questionnaire. For instance, Hack and co-workers (2007)
used the Informed Consent Questionnaire (ICQ), Hietanen and co-workers (2007) used
the Quality of Informed Consent (QuIC) questionnaire, and Hutchinson and co-workers
(2007) used the Clinical Trial Decision Questionnaire and in addition a self-
administered questionnaire. The focus of these three studies was cancer patients. In
addition, there were some studies without a specific informed consent questionnaire
(e.g. Baker et al. 2000).
The reviewed studies were focused as follows:
Information in: healthy volunteers participating in a phase 3 clinical trial (Fortun et al.
2008), prostate-antigen screening (Gattellari & Ward 2005), clinical trial in breast
oncology (Hack et al. 2007), representative cerebral artery infarction patients and
representative stroke patients (Hofmeijer et al. 2007), adult outpatients (Kruse et al.
2000) patients on hemodialysis or in a prerenal state (Lynöe, Näsström & Sandlund
2004), cancer patients (Strevel et al. 2007), and colorectal cancer screening for elderly
patients (Wolf & Schorling 2000).
Understanding and competence in: participants in a trial of a new drug for
hypertension and participants in a trial of an anaesthetic in a sterilisation procedure in
women (Bjørn, Rossel & Holm 1999), outpatients (Campbell et al. 2008), cancer
patients (Coyne et al. 2003), outpatients with schizophrenia or related psychotic
disorders (Dunn et al. 2001, 2002), patients with unstable angina pectoris / non-Q-wave
acute myocardial infarction (Kucia & Horowitz 2000), mentally ill prisoners (Moser et
al. 2004), volunteers in biomedical research in four clinical research centres (Paris et al.
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2007), patients with schizophrenia or depression (Stiles et al. 2001), and voluntary adult
participants (Sudore et al. 2006).
Voluntariness in: patients  who  were  scheduled  for  minor  surgery  with  general
anaesthesia (Treschan et al. 2003). And decision-making in: patients  with  asthma  or
stable angina (Baker et al. 2000), older assisted-living residents at a high risk for
cognitive impairment (Black et al. 2008), screening for prostate cancer (Davison et al.
1999), colorectal, breast and lung cancer patients (Hutchinson et al. 2007a), participants
in a breast cancer prevention trial (Juraskova et al. 2008), women asked to participate to
a double-blind randomised drug trial (Lovegrove et al. 2000), genetic testing in women
(Mancini et al. 2006), and outpatients referred to the urology surgery (Westberg et al.
2004).
Enhanced informed consent process with different methods: in older inpatients in
acute assessment (Adamis et al. 2005), patients with asthma (Dresden & Levitt 2001),
primary care clinics outpatients (Dunlop et al. 2007), Down syndrome screening
(Hewison et al. 2001), voluntary adult participants (Ishii & Ohashi 2007), voluntary
members  of  the  public  for  screening  of  type  2  diabetes  (Kellar  et  al.  2008),  research
subjects from five different randomised clinical trials (Lavori, Wilt & Sugarman 2007),
emergency department patients (Marco 2008), patients with Alzheimer disease of mild
cognitive impairment (Mittal et al. 2007), and seriously ill patients mental and medical
conditions (Wirshing, Sergi & Mintz 2005).
Improvement of design and conduct of randomized trials: in patients from primary
care clinics participating in intervention for depression (Dobscha et al. 2005), patients
undergoing prostate testing for cancer and treatment (Donovan et al. 2002), and
informed consent document developed by Gulf War veterans (Peduzzi et al. 2002). And
others: professional’s communication skills in context with cancer patients (Brown et
al. 2007, Hietanen et al. 2007), recruitment and retention to trials in injection drug users
(Garfein et al. 2007), financial interests in patients with coronary artery disease
(Weinfurt et al. 2008a), and patient’s perspective of the international cohort study in
acute myocardial infarction (Yuval et al. 2000).
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2.7  Summary of theoretical background
Informed consent is an essential part of high ethical quality of scientific research with
human participants. Informed consent is universally known and recogonized. However,
the global clinical research enterprise has become increasingly complex from
operational, regulatory, and ethical perspectives (Chanaud 2008). One major challenge
is that researcher’s must be aware of the large amount of regulations some of which
may be confusing, conflicting and difficult to access. The reason for these regulations is
the necessity of protecting the individual integrity and privacy of research participants
(Lötjönen 2002).
Figure 1 summarizes the theoretical background of this thesis. In the centre is the
consent provider who makes the finally decision of participation to research. The
aspects to decision-making come from ethics, information provided to and collected
from informants. The primary informed consent process is a personal resolution to the
posed question: Are you willing to participate in our study?
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Figure 1 Theoretical background of informed consent (adapted from Beauchamp & Childress
2001; Leino-Kilpi et al. 2002)
Information
· content
· intelligibility
· amount
· manner (verbal,
written, multimedia)
Informant
· who (doctor, nurse,
researcher)
· expert (knowledge,
ability, attitude,
ethical issues)
Ethics
· autonomy
· laws, statutes,
guidelines, rules
CONSENT PROVIDER
REJECTIONPREREQUISITES
· Information
· Competence
· Understanding
· Voluntariness
DECISION-
MAKING CONSENT
INFORMED CONSENT
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3  AIM OF THE STUDY
The aim of this study was to add empirical knowledge about informed consent in health
research.  The  purpose  of  the  present  thesis  was  to  describe,  analyze  and  evaluate  the
realization of informed consent in health research as expressed by voluntary adult
research participants. This thesis had two phases: the pilot study and the primary
informed consent study; though the emphasis on phase 2.
Phase 1 The Pilot Study (Original publication I)
The purpose of this stage was to develop a questionnaire designed to evaluate informed
consent in health research and to test it in a pilot study.
Individualized research questions at Phase 1 were:
1 How informed consent is realized in a clinical research project?
2 Is the created questionnaire (interview schedule) a useful tool for monitoring the
quality of the informed consent process?
Phase 2 Informed Consent Study (Original publications II–IV)
The purpose of this primary stage was to describe, analyze and evaluate the realization
of informed consent in a population-based exercise and diet intervention study.
Individualized research questions at Phase 2 were:
1 How the key elements of informed consent (information, understanding,
competence, voluntariness and decision-making) are realized in an exercise and
diet intervention study?
2 What factors are associated with the participant’s comprehension of information
received in the exercise and diet intervention study? Supplementary question: Is
understanding related to long-term continuation in the intervention trial?
3 Is informed consent related to success in the exercise and diet intervention as
evaluated at 12 months?
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4  METHODS
4.1  Study populations and data collections
The Pilot Study (Phase 1)
The study population consisted of subjects (N=32) who participated in a clinical
research project evaluating the effects of betaine on cardiovascular risk factors in high
risk subjects with the metabolic syndrome. This ‘Betaine’ Study was arranged in the
Department of Clinical Nutrition, University of Kuopio. The participants, aged 36–66
years, had impaired fasting glucose or impaired glucose tolerance or type 2 diabetes and
at least two of the following: blood pressure > 140/90 mmHg, serum triglyceride
concentration >1.7 mmol/l and/or HDL-cholesterol <0.9 mmol/l, waist-to-hip ratio
>0.90 in men and >0.85 in women and/or BMI >30kg/m², microalbuminuria. The
kidney, liver and thyroid functions of the participants had to be normal.
The data of the Pilot Study were collected by interview between May and June 2004 in
the Department of Clinical Physiology and Nuclear Medicine, Kuopio University
Hospital. Before the interviews, the participants received oral information, an
information letter and a request to return a form containing their contact details in the
return envelope. Of the 32 persons invited, a total of 26 (16 male and 10 female) took
part. Those who did not return the contact details form were not approached again.
The Informed Consent Study (Phase 2)
The study population at this primary stage consisted of subjects who are participating in
a randomized controlled intervention trial on the effects of regular physical exercise and
diet arranged by the Kuopio Research Institute of Exercise Medicine (DR’s EXTRA:
Dose-Responses to Exercise Training. A randomized controlled trial on the effects of
regular physical exercise and diet on endothelial function, atherosclerosis and
cognition). In 2002, a representative 15 % sample (N=3000) of 55- to 74-year-old men
and women living in the city of Kuopio (in eastern Finland) were invited to participate
in an exercise and diet intervention study. Of the participants initially invited, 2062
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expressed an interest in participating and 1410 subjects participated in all four baseline
examinations between April 2005 and November 2006.
The main exclusion criteria at entrance were conditions that would prevent safe
engagement in the prescribed exercise training, malignant diseases as well as other
conditions preventing potential participants from co-operating, as judged by the
research physicians. The participants were randomized into six intervention groups: 1)
Reference, 2) Aerobic Exercise, 3) Resistance Exercise, 4) Diet, 5) Aerobic Exercise
and Diet, 6) Resistance Exercise and Diet. These interventions are intended to continue
for four years. The formation of the study population of the DR’s EXTRA Study is
presented in figure 2.
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Figure 2 Formation of study population in DR’s EXTRA Study (Hassinen 2008, Komulainen
2008)
n= 16 010
Original subject source of men and women aged 55–74 years in 2002
n=3000
Random sample,
invited to the study in 2002
n=2062
Willing to participate
Run-in phase in 2003–2005
n=1829
Invited to the baseline
examinations in 2005
n=1479
Participated in the baseline
examinations in 2005–2006
n=1410
Randomization into six
intervention groups
Death 20
Severe disease 48
Moved elsewhere 13
Not interested 647
No response 210
Death 9
CVD 3
Cancer 2
Dementia 3
Musculoskeletal disease 4
Other disease 27
Loss of motivation 59
Moved elsewhere 20
Unknown reasons 103
Unreachable 3
Death 24
CVD 12
Cancer 12
Dementia 4
Musculoskeletal disease 15
Other disease 29
Loss of motivation 103
Moved elsewhere
Personal reasons
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20
Unknown reasons 87
Unreachable 6
CVD 18
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Musculoskeletal disease 8
Other disease 19
Loss of motivation 22
Moved elsewhere 1
Aerobic
Exercise
n=234
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Exercise
n=236
Dietary
n=236
Aerobic
+ Dietary
n=234
Resistance
+ Dietary
n=234
Reference
n=236
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The interventions protocol in the DR’s EXTRA Study is as follows: Participants in the
Reference group have been given general public health advice on regular physical
activity for a minimum of 30 minutes of moderate exercise on most days of the week
causing an exercise energy expenditure (EEE) of 750–1000 kcal (3.1–4.2 MJ) per week.
Each exercise group started the intervention with a four-week aerobic exercise period to
accustom the individuals to physical exercise.
Participants in the Aerobic Exercise group have been prescribed an individualized
training program at an intensity corresponding to ventilatory aerobic threshold (at 55–65
% of the maximum level). The main exercise models are walking, skiing, jogging-
running, pole walking, biking and swimming. In addition, the participants in this group
have been further divided randomly into two subgroups (stratified by age and gender)
after 6 months intervention: EEE of 1000–1500 (4.2–6.3 MJ) or more than 1500
kcal/week, by varying the exercise frequency and duration. The training frequency has
been gradually increased during the following 5–11 months to either two or four
sessions per week. Training intensity has been monitored either by a personal heart rate
recorder or by artery palpation. (Rauramaa et al. 2004, Haskell et al. 2007, Nelson et al.
2007.)
Resistance Exercise group have been given a training program according to the
guidelines of the American Heart Association (AHA) and American College of Sports
Medicine (ACSM). After the baseline strength measurement, the subjects participated in
supervised, individually prescribed progressive strength training for 6–12 months (from
40–50 % to 70–80 % of 1 repetition maximum (RM)) twice a week for all the major
muscle groups (12 exercises, 12 repetitions, 2–3 sets; e.g. 60/70/80 % for muscle
hypertrophy). One third of the total volume of training included leg extensor with light
loads only (40–50 % of 1 RM) but executed all repetitions as explosively as possible
(rapid muscle actions) in order to stimulate the neural control of muscle contraction.
The duration of each training session has been from 45 to 60 minutes, plus 5 minutes
aerobic warm-up, and 10 minutes muscle stretching. Participants were supplied with a
personal smart card, with details of the training program and which kept a record of all
exercises. In addition, the participants in this group have been given the general public
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health advice on aerobic exercise. (Rauramaa et al. 2004, Haskell et al. 2007, Nelson et
al. 2007.)
Participants in the Diet group have been given personal dietary counselling on a low fat,
high fibre diet enriched with omega-3 fatty acids (max 30 E% from fat), and the general
public health advice on aerobic exercise. The participant in the Combined Diet and
Exercise groups have followed aerobic (EEE 1000–1500 kcal/week) or resistance
exercise (2 exercise sessions per week), respectively, and been given personal dietary
counselling.
The data of the Informed Consent Study were collected between August 2005 and June
2007 using a semi-structured questionnaire (Appendix 3). During the three-month
intervention visit of DR’s EXTRA Study at Kuopio Research Institute of Exercise
Medicine, the questionnaire was given to all able and willing participants (n=1324) who
were still involved in the study. The participants received oral information and an
information letter (Appendix 2) with a return envelope during this intervention visit.
The  participants  were  given  two weeks  time to  return  the  questionnaire.  Persons  who
did not answer the first time were not reminded. The response rate was 91 % (n=1200).
Five questionnaires were rejected due to insufficient answers, and thus the total number
of accepted questionnaires was 1195. Formation of study population for Informed
Consent Study is presented in figure 3.
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Figure 3 Formation of study population in Informed Consent Study
The data on success in DR’s EXTRA Study after 12 months intervention were measured
by the intervention-group personnel. The participants (n=597) included here are a
subpopulation of the whole randomized sample. This subgroup consists of three
intervention groups: Aerobic Exercise, Resistance Exercise and Diet. In addition,
participants’ long-term continuation in the DR’s EXTRA STUDY was evaluated two
years after the randomization.
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questionnaire
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n=1324
Dropout within three months 42
Did not attend intervention visit 22
Refused to fill in questionnaire 9
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Disease
Other unspecified reasons
1
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Three months
intervention
DR’s EXTRA Study
n=1410
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Exercise
(n=234)
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Exercise
(n=236)
Dietary
(n=236)
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+ Dietary
(n=234)
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+ Dietary
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4.2  Questionnaire
This study used a new questionnaire for assessing informed consent in health research.
The development of the questionnaire was based on international declarations and
guidelines of research ethics (e.g. Declaration of Helsinki, ICH–GCP Guidelines for
Clinical Trials), on national legislation, codes and guidelines of ethics (e.g. Medical
Research Act, Finnish Medical Associations code of medical ethics, Guidelines of
ETENE and TUKIJA), on relevant literature (e.g. Beauchamp & Childress 2001, Leino-
Kilpi et al. 2002) and on a pilot study (Original publication I). In the Pilot Study the
questionnaire was used and designated as interview schedule. The development process
of the questionnaire is depicted in figure 4.
The Pilot Study resulted in only minor adaptations to the questionnaire: Two questions
were deleted and two were added. The deleted questions dealt with the starting point
and ending of the exercise and diet intervention study. The added questions dealt with
confirmation of received information and confirmation of understanding the
information. A few questions were relocated to improve the inner coherence of the
questionnaire. The Likert-scale was simplified from 7-point to 5-point (e.g. Burns &
Grove 2001). Taking into account the method of data collection (a questionnaire survey
study) the verbal presentation of all questions was carefully considered and clarified.
The improved questionnaire was tested preliminarily (June 2005) by five persons who
had been participants in a life-style intervention study organized by Kuopio University
Hospital (Lifestyle intervention in patients with obstructive sleep apnoea).
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Figure 4 Development of the questionnaire
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The questionnaire included 44 questions: 1) background information (14 questions), 2)
information, understanding and competence (16 questions), 3) voluntariness and
decision-making (14 questions). The questionnaire contained multiple-choice questions,
yes/no questions, short specifying open questions and a scale of 1–5 (Likert-scale). On
this scale, 5 was the most positive choice (example: completely enough, I understood
completely, significant possibility to exert influence) and number 1 was the most
negative (example: I received no information, I did not understand at all, no possibility
to influence). The structure and content of the questionnaire are described in Original
publication II (see Table 1) and the whole questionnaire is shown in Appendix 3.
4.3  Data analysis
In the Pilot Study, the statistical analyses were performed using SPSS for Windows
(SPSS Inc., Chicago, version 11.5). The following steps were taken in the data analysis
phase: First, the 7-point Likert scale answers were turned into three categories: poor (1–
2), moderate (3–5), good (6–7). The explanation for this classification is that this
modification makes the data analyses more reliable when the amount of participants is
small. Second, frequencies and percentages were calculated on categorical and
numerical discrete data.
In the Informed Consent Study, all statistical analyses were performed using SPSS for
Windows (SPSS Inc., Chicago, version 14.0, 2005). The main aim of the statistical
analysis was to use the information gained from a sample of individuals to make
inferences about the relevant population (Altman 1999).
At individualized research question number one (How the basic elements of informed
consent are being realized in exercise and diet intervention study?) the statistical
methods were descriptive.  The following steps were taken in the data analysis phase:
First, the answers to the 5-point Likert scale were turned into three categories: poor (1–
2), moderate (3) and good (4–5). The explanation for this modification is that this
classification is used in Phase 1, individualized research question one. In addition, clear
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minority  of  the  participants  had  chosen  answer  alternatives  two  or  four.  Second,  to
describe the data, frequencies and percentages were calculated. Third, differences
between categorical variables (sex, age, education) were tested using cross-tabulations
and chi-square tests. A p-value less than 0.05 was considered to be statistically
significant. This means that if the p-value was small, the null hypothesis was rejected as
implausible. When p-value was >0.05 it was taken to indicate that insufficient
information was available to discount the null hypothesis. (Campbell & Machin 1993.)
With  respect  to  individualized  research  question  number  two  (What factors are
associated to participant’s comprehension of information received in the exercise and
diet intervention study?) the understanding of the received information was measured
by the respondents’ answers to three questions: 1) What is your opinion of the
intelligibility of information given in the exercise and diet intervention study? 2) What
is the purpose of the exercise and diet intervention study? 3) What is your opinion of the
sufficiency of the confirmation by research personnel that you have understood the
information given in the exercise and diet intervention study?
The following steps were taken in the data analysis phase: First, the answers to the 5-
point Likert scale were turned into two categories: poor to moderate (1–3) and good (4–
5). The explanation for this classification is that also those participants who chose the
moderate choice were not unambiguously satisfied with the information given. Second,
frequencies and percentages were calculated to describe the data. Third, in order to
examine the associations of the response variables and potential predictors, univariate
analyses were performed. Fourthly, backward-directed stepwise multiple logistic
regression models were used to identify correlates of variables concerning participants’
understanding of the information received. P-values less than 0.05 were considered
statistically significant. In addition, the participants’ long-term continuation in the
intervention trial with relation to the above-mentioned three questions was evaluated
two years after the randomization. The lists of variables used in research question two
and their classifications are presented in detail in Original publication III (see Table 1).
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The multiple regressions examined the simultaneous relationship between one
dependent variable and a number of independent variables (Campbell & Machin 1993).
In general, a regression model is a statistical model for describing the relationship
between one or more explanatory variables and the response (dependent) variable. The
purpose  of  statistical  modelling  is  to  fit  the  best  model  from  a  medical  or
epidemiological point of view that describes this relationship. A simple linear
regression model describes how much a continuous quantitative response variable
depends on the explanatory variable. In the multiple regression model, a linear
combination of several explanatory variables is included. (Everitt & Palmer 2005.)
Finally, with respect to individualized research question three (Is informed consent
related to success in exercise and diet intervention as evaluated at 12 months?) the
success of intervention was measured through evaluation by the intervention-group
personnel via the following two questions: 1) How intervention has been implemented
in the exercise and diet intervention study after 12 month intervention? 2) Have the
participants been successful in the exercise and diet intervention study after 12 month
intervention as measured by changes in their activities concerning exercise or diet?
Three intervention groups were taken into account in this data analysis (Aerobic
Exercise, Resistance Exercise, and Diet) and with the three other groups omitted. The
reason for this decision was that in Reference group the participants did not receive any
intervention and in combined groups (Aerobic Exercise and Diet, Resistance Exercise
and Diet) two intervention-group personnel evaluated separately the participant’s
success with respect to the different aspects of the intervention. In addition, the data
analysis was restricted to those participants who responded to the Informed Consent
questionnaire.
The following steps were taken in the data analysis phase: First, the answers to the 5-
point Likert scale were turned into two categories: poor to moderate (1–3) and good (4–
5). Second, frequencies and percentages were calculated to describe the data. Third,
univariate analyses were calculated between every examined variable. The multivariate
analyses utilized those variables which had a p-value <0.1 in the univariate analyses.
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Fourthly, stepwise multivariate analyses (Ordinal Regression) were used to identify
correlates of variables concerning realization and success. Multivariate ordinal
regression model were used to identify significant predictors of outcome these being set
at p<0.05. The list of variables used and their classifications are presented in detail in
Original publication IV (see Table 1).
The questionnaire included also short supplementary open questions. The idea was that
these answers would provide a more in-depth understanding of the quantitative data (cf.
Malterud 2001). The content analysis was used to collate, synthesize and refine this
qualitative data. The words in the open questions were classified into a few categories
chosen according to their theoretical importance. This technique provides a systematic
means of measuring the frequency, order or intensity of occurrence of words, phrases or
sentences (Burns & Grove 2001).
4.4  Ethical considerations
All of these studies (the Betaine Study, the Pilot Study, the DR’s EXTRA Study and the
Informed Consent Study) were approved by the Research Ethics Committee of the
Hospital District of Northern Savo (permit numbers: 98/2003, 66/2004, 105/2002,
99/2005). This thesis was performed by adhering to good scientific practice. The main
principle in research involving humans is primacy of the research participant. This
means  that  participant’s  benefit  and  welfare  should  be  placed  ahead  of  any  benefit  to
society or science. All participants had to be voluntary and they had to give their
informed consent to research in question. (Declaration of Helsinki 2008.) Therefore,
written informed consent was obtained. Participants were given a copy of the consent
form and they were told that they could withdraw at any phase. In the Betaine and Pilot
Study the informed consent was asked separately. The DR’s EXTRA Study and
Informed Consent Study used a common informed consent form.
Before obtaining the written consent, the research participants were given written and
verbal information and also time to consider. Those who did not display any interest
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were not reminded or persuaded. The research participants did not obtain any
compensation for their participation. The data were coded and treated confidentially
(Henkilötietolaki 1999, Personal Data Act 1999, European Commission 2007). This
coding system means that personal details can still be identified by specific requests and
safeguards (European Commission 2007).
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5  RESULTS
5.1  Evaluation of the questionnaire
The results  of  the  Pilot  Study  are  presented  in  detail  in  Original  publication  I.  In  this
context, only the result of the development of the questionnaire is shortly described.
According to the results of the Pilot Study, the initial questionnaire appeared to be
suitable in its present form. The assessment by the respondents was that the
questionnaire used was mainly clear and in an intelligible form. The strength of the
questionnaire was that there were not too many number of questions (44 questions),
harmony of classifications used and similarity of statements.
There were, however, two questions in which the respondents required verbal help
almost every time. Both questions were concerned to more common opinions, whereas
other questions were related to experiences gained in the Betaine Study. Special
attention was paid to these two questions when further developing the questionnaire and
devising written instructions on how it was to be filled in. Although the data collection
method in the Pilot Study was interview, this phase 1 confirmed that it is possible to
investigate informed consent by means of a questionnaire.
5.2  Results of the Informed Consent Study
The results of the Informed Consent Study are presented in a similar manner as in the
original publications. The results are reported by individualized research questions.  The
total number of accepted questionnaires in the Informed Consent Study was 1195. The
respondents (586 male and 609 female) ranged in age from 57 to 78 years (66 ± 5
years). Background information is presented in detail in Original publication II (see
Table 2).
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5.2.1 Realization of the key elements of informed consent
Information Most respondents (86 %) reported that they had so far received complete
enough or  sufficient  information  about  the  exercise  and  diet  intervention  study  (DR’s
EXTRA). There were no statistically significant associations between sex, age or
education  and  opinions  about  the  amount  of  information  given.  However,  some
participants (3 %) reported that they had not received information at all or that the
information about the study was completely insufficient. In addition, the majority of the
respondents (66 %) considered that the research personnel had confirmed satisfactorily
that the participant had received sufficient information. About one in five of the
respondents (19 %) felt that this matter had been taken into account moderately well.
However, 15 % reported that confirmation of the received information was completely
insufficient or insufficient.
In addition, there was interest in elucidating what the participants felt was sufficient
information. Therefore specific questions were asked concerning the information. Most
respondents (74 %) knew the people responsible for the research and nearly all (98 %)
who had wished had been able to contact the researcher when necessary. Nearly half of
respondents (46%) reported that they had been sufficiently informed about why they
had been chosen as subjects in the study. On the other hand, 34 % of the respondents
reported that they did not know this reason. About half of all respondents (54 %)
considered that they had been sufficiently informed of the possible negative effects of
the study. However, 31 % of the respondents felt that they had received no information
or completely insufficient information about the possible negative effects. Almost all
respondents (95 %) were aware of their  right to withdraw from the study at  any point
though only 6 % had actually considered withdrawing. The reasons why participants
had considered withdrawing from the DR’s EXTRA are presented in detail in figure 5.
65
Figure 5 Reason why participants had considered withdrawing
Own health become poorer
(n=27, 42 %)
Practical difficulties related to
participation in research
(n= 14, 22 %)
Research had not corresponded to
expectations
(n=10, 15 %)
Unpleasant research experience
 (n=8, 12 %)
Other personal reasons (n=6, 9 %)
’Laziness.’ (n=1)
’Sometimes I do not fancy going to
research institute.’ (n=1)
’I do not feel being able to.’ (n=1)
‘Sometimes it feels too restricting.’
(n=1)
’I had a bad day and situation in life.’
(n=1)
‘I cannot say why.’ (n=1)
Examples of answers:
’I got bad feeling from the sugar
tolerance test.’
‘Once I received mistreatment.’
’Nearly stressful paperwork.’
’Unpleasant, obnoxious heart exercise
test.’
’Too small gymnasium and too few
places in car park.’
’I feel that I do not benefit from this
study.’ (n=4)
’I wish to join another intervention
group.’(n=4)
‘Difficult in implementing the
instructions.’ (n=1)
‘Long-winded research.’ (n=1)
Takes a lot of time. (n=4)
Difficulties in arranging time of work.
(n=4)
Distance between home and research
institute. (n=6)
Examples of answers:
Knee arthrosis pain.
Condition occasionally poor.
Developed cancer.
Backache.
Fatigue and prevalent health.
Participant’s possible reason for withdrawing from study
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Nearly half of the respondents (49 %) did not know how the DR’s EXTRA Study had
been funded and whether it was sponsored. On the other hand, 35 % of the respondents
believed  they  knew  these  facts.  Most  of  respondents  (68  %)  were  unaware  of  the
intention of reporting or publishing the results. Only 12 % of the respondents believed
that they knew the financial connections of the researchers to the DR’s EXTRA Study.
Most  of  respondents  (75  %)  did  not  know this.  Almost  all  of  the  respondents  (96  %)
knew that they would not receive any financial compensation for participating. A few (3
%) answered that they did not know whether they would receive any financial
compensation and very few (<1 %) reported that they would obtain some compensation.
In addition, some respondents (1 %) had written comments related to this issue. For
example, some stated that they wished to have compensation for travel expenses (n=4)
or recompense for their trouble (n=2). On the other hand, some wrote that they receive
recompense them for their trouble, e.g. free examinations with a medical certificate, use
of a gymnasium and guidance (n=5), improvement in their own condition and health
(n=3) and possibility to participate during work hours (n=1).
At the end of this section, the respondents were asked whether they needed more
information. Most of them (81 %) reported that they had received enough information.
There was no statistically significant association between sex or age and the need to
obtain more information. However, there was a statistically significant association
between education and the requirement for additional information (p<0.001), so that the
higher the education of the respondent, the more information he/she required.
Understanding and Competence Almost all respondents (89 %) reported they had
received information in an intelligible form. Again, there were no statistically
significant associations between sex, age or education and opinions about intelligibility
of  the  information  given.  The  majority  of  the  respondents  (66  %)  considered  that  the
research personnel had confirmed satisfactorily that the participant had understood the
information received. A fifth of the respondents (19 %) reported that this matter had
been taken into account moderately well. Again, it is noteworthy that 14 % of the
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subjects  reported  that  confirmation  of  understanding  the  information  given  was  either
completely insufficient or insufficient.
The respondents’ ability to understand was also evaluated in an open question
concerning the purpose of the DR’s EXTRA Study. These replies confirmed the
impression that the information had been understood appropriately by a majority of the
study population. Most of the respondents (82 %) answered correctly. Only 5 % of the
replies indicated that the respondent had not understood the purpose, and 2 % answered
that they did not know or remember the purpose of the study. In addition, 11 % of the
questionnaires lacked an answer to this question.
Voluntariness Almost all respondents (99 %) reported that they had participated in the
DR’s EXTRA Study of their own free will and without coercion. Three respondents felt
that they had been coerced into participating. Only one of these told why he/she felt that
way. In his/her answer this respondent said that the adviser of the intervention group
had made him/her continue.
Half of the respondents (50 %) reported, however, that it was their responsibility to
participate. For example, these were: obligation to one’s own health (29 %), helping
other people now and in the future (29 %), willingness to assist in research (18 %),
positive attitude toward participating in projects like this (6 %), promising means
commitment to the project (5 %), important aim of the project (4 %), belonging to the
group selected for this project (3 %) and also some individual feelings of responsibility.
The associations between responsibility to participate and sex (p<0.001), age (p<0.001)
and education (p=0.001) were statistically significant, so that men, older people and the
less educated felt more responsibility to participate.
Decision-making Willingness to participate in research projects was greatly influenced
by desire to help other people (69 %), chance to obtain help for one’s own disease (75
%) and an opportunity to participate in treatment and/or examinations (82 %). On the
other hand, the factors that did not or only slightly influenced willingness to participate
were:  willingness  to  please  research  personnel  (10  %),  fear  of  annoying  the  hospital
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personnel (3 %), and whether family or friends or many of their colleagues at work have
participated in the same research projects (6 %). According to the respondents, the
illness of a loved one led to divided opinions in relationship to the factors influencing
participation (great influence 42 %, no influence 39 %).
Furthermore, the participants were asked what different people could have influenced
their  decision  to  participate  in  research  projects.  According  to  a  majority  of  the
respondents,  only  the  researcher  (doctor)  (77  %),  research  nurse  (67  %)  and  research
personnel (55 %) were the people who are able to influence their decision-making
concerning participation. These results are reported in detail in Original publication II
(see Table 4).
Almost all respondents (99 %) reported that the period of consideration before the
decision to participate in the DR’s EXTRA Study was sufficient. Most respondents (64
%) had decided to participate immediately, and the second most common period of time
for consideration was from one day to a week (19 %). The other respondents had
thought about participation for either less than a day (10 %) or more than a week (5 %).
There were also respondents who did not remember how long they thought about
participation  (2  %).  It  is  noteworthy  that  13  % of  the  respondents  did  not  answer  this
question or answered so that it could not be classified. Most of the respondents (74 %)
had not discussed the research project with people other than the researcher before
giving  their  consent.  It  was,  however,  common that  conversations  took  place  between
respondents and their spouses (64 %). Other individuals who may have been consulted
were children, relatives, friends, acquaintances in the same project participating, other
doctor or nurse, workmate or employer.
Most of the respondents (69 %) remembered having given written consent before the
examinations began. Nearly a fifth of the respondents (17 %) remembered that they had
given written consent after they had started the project. Seven percent remembered
having given consent orally, and five percent believed that they had started without
providing any specific consent. Two percent did not remember or had no concept of
how their consent had been confirmed.
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5.2.2 Factors associated with participant’s comprehension of information received
Multivariable analyses were conducted on this second research questions. The Original
publication III presents the results of the logistic regression models in detail: estimates
of the Odds Ratios (OR), their 95 % confidence intervals and the p-values of the most
predictive variables selected by the stepwise procedure (see Tables 3–5).
There were statistically significant associations between opinions about the
intelligibility of the information given and 1) education (p=0.01), 2) adequacy of time
for the first visit in the DR’s EXTRA Study (p=0.01), 3) adequacy of received
information at the DR’s EXTRA Study (p<0.001), and 4) sufficient confirmation by the
research personnel of the participant’s understanding of the information given at the
intervention (p<0.001). Participants who were highly educated were most satisfied with
the intelligibility of the given information. Participants who were most content with the
time used for the first  visit,  or with the received information, or with the confirmation
by the research personnel that the participant had understood the information given at
the  DR’s  EXTRA  Study  were  also  most  satisfied  with  the  intelligibility  of  the
information provided. These results are presented in detail in Original publication III
(see Table 3).
In addition, there were statistically significant associations between knowledge of the
purpose of the DR’s EXTRA Study and 1) education (p<0.001), 2) health (p=0.01), 3)
satisfaction about intelligibility of the information given (p=0.03), and 4) adequacy of
confirmation by the research personnel of the participants’ understanding of the
information given at the DR’s EXTRA study (p=0.03). Better educated participants and
those who felt themselves to be healthier were most aware of the purpose of the study.
In addition, participants who were most content with the intelligibility of the
information given, or with the research personnel confirmation of participant
understanding the information given at the DR’s EXTRA were also most aware of the
purpose of the study. These results are presented in detail also in Original publication III
(see Table 4).
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Furthermore, there were statistically significant associations between opinions about the
adequacy of the confirmation by the research personnel that the participant had
understood the information given and 1) adequacy of received information during the
intervention study in question (p<0.001), and 2) adequacy of the confirmation by the
research personnel that the participant had received enough information during the DR’s
EXTRA Study (p<0.001). Participants who were most content with the received
information or with the confirmation by the research personnel that he/she had received
sufficient information at the DR’s EXTRA Study were also most satisfied with that the
research personnel had confirmed that they had understood the information given.
Again, these results are presented in detail in Original publication III (see Table 5).
There were no statistically significant associations between participants’ long-term
continuation and their understanding of the trial. In addition, no significant associations
were found between long-term continuation and sex, age or education. However, there
was  a  statistical  association  (p  <  0.001)  between  opinion  of  one’s  own  health  and
continued participation in the intervention evaluated after two years. Participant who
felt themselves to be healthier were more likely to continue involvement in the DR’s
EXTRA Study.
5.2.3 Participants success in exercise and diet interventions after 12 months
In this last stage three intervention groups were analysed (Aerobic Exercise, Resistance
Exercise, and Diet). This subpopulation consisted of 597 participants. The Original
publication IV presents the results of the ordinal regression model in detail: p-values
from  all  steps,  and  p-values,  estimates,  and  standard  errors  of  the  most  predictive
variables selected by the stepwise procedure of the ordinal regression model (see Tables
2–3).
The age of this subpopulation (293 male and 304 female) ranged from 57 to 78 years
(mean 67 years, SD 5 years). The majority of the participants (75 %) were married or in
cohabitation without marriage. Participant’s education level was categorized as follows:
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37 % of participants had vocational school or course background, 26 % had college-
level training, 22 % of participant’s had no professional training, and 16 % had
academic degree education. The clear majority of the participants (87 %) were retired
and  the  rest  (13  %)  were  working  either  full-time  or  part-time.  A  minority  of  the
participant’s (37 %) had earlier participated in some research project. Above half of
participant’s (56 %) had the opinion that their  health was moderate and 37 % felt  that
their health was good. Only 4 % reported that their health was remarkably good, 3 %
poor and less than 1 % felt that their health was remarkably poor.
Approximately half of participants (54 %) had attained a good result in aerobic exercise,
resistance exercise, or diet interventions. About third of participants (35 %) had
achieved a moderate result and a minority of participants (12 %) had a poor result.
There were statistically significant associations only between realization of
interventions and participants knowledge of the purpose of the DR’s EXTRA Study
(p<0.001). Participants who were most aware or had understood the purpose of the
study had also attained better results at their intervention evaluated after 12 month. The
results are presented in detail in Original publication IV (see Table 2).
Nearly half of participants (47 %) had added or improved some personal activity in
some  sector  of  exercise  or  diet.  Almost  fifth  of  participants  (18  %)  had  added  or
improved some personal activity in many sectors of exercise or diet. One third of the
participants (33 %) experienced no changes in their activities concerning either exercise
or  diet  and  only  a  few  participants  (1  %)  reduced  or  worsened  their  activities.  There
were statistically significant associations between success in interventions and 1)
working status (p=0.02), and 2) participants’ knowledge of the purpose of the DR’s
EXTRA Study (p=0.04). Participants who were still in working life or who were most
aware or had understood the purpose of the study had also succeeded better in the
intervention when this was evaluated after 12 months. These results are also presented
in detail in Original publication IV (see Table 3).
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5.3  Summary of the main findings
To  summarize  the  main  findings,  according  to  a  majority  of  the  participants,  the  key
elements of informed consent (information, understanding, competence, voluntariness,
and decision-making) were well realized in the exercise and diet intervention study in
question. This means that the majority of the participants believed that information
given was adequate and had been presented in an intelligible form. The competence of
the participants was judged to be sufficient. The participants considered that their
decision-making had been voluntary, and the majority felt that confirmation and
verification of informed consent were also carried out well. These results are in
agreement with the results of the Pilot Study. In addition, compared to background
variables, higher education and satisfaction with one’s own health were statistically
significantly associated with adequate comprehension of the provided information.
About  half  of  the  participants  had  achieved  good  results  in  the  intervention  after  one
year. Nearly half of the participants had added to or improved their own activity in some
sector of exercise or diet. Significant associations were found between performance and
success in the interventions and participants’ knowledge of the purpose of the study,
and between success in interventions and working status. Furthermore, participants who
felt themselves to be healthy were more likely still to be participating in the intervention
after two years.
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6  DISCUSSION
The goal of this thesis was to analyze how well informed consent could be achieved in
population-based health research from the point of view of voluntary adult research
participants. This chapter discusses the key elements of informed consent and ways of
enhancing the informed consent process by comparing the results of this thesis with
earlier studies. In addition, this chapter evaluates the validity, reliability and study
limitations of this thesis.
6.1  Discussion of the key elements
6.1.1 Information
The  majority  of  the  participants  estimated  that  information  given  on  the  exercise  and
diet intervention study was sufficient and had been presented in an intelligible form.
The participants had received both written and verbal information. Written information
was mailed to potential participants at the very beginning; and when the participant
started the baseline study, written information was given again to ensure that it had been
received. In addition, the participants received personal counselling after they had been
randomized into the intervention groups. All participants received the same information
until they started in their intervention groups.
The quality of the informed consent or assent process is directly related to the quality of
the information provided (Koren et al. 2003, cf. Kaptchuk et al. 2006). The general
population appears to have only a limited knowledge of clinical trials. Therefore it is
necessary to provide potential research participants with adequate information.
(Campbell et al. 2008.) In addition, numerous anthropological studies have pointed out
that participants are rarely able to recall what they have agreed after signing an
informed consent form (European Commission 2007).
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There are still many unanswered questions about the ideal informed consent process, the
best way to appropriately inform potential research subjects of risks and benefits in a
way that will improve their understanding and retention of information presented
(Marco 2008). Thus, the critical part of the process is how to inform (how we deal with
‘informed consent’). For instance, despite efforts to improve informed consent, clinical
trial accrual continues to be poor, and this may be related to the lack of sufficient
informational support for patients. (Hack et al. 2007.) Therefore, providing information
e.g. both orally and writing and providing sufficient time for consideration was stated to
improve the informed consent also in a group of severely ill elderly patients (Lynöe,
Näsström & Sandlund 2004).
The literature describes many different strategies which may enhance participant’s
receipt of information. For example, one study examined the benefit of providing a
clinical trials information handbook on patient knowledge, perceptions, and likelihood
of participation, and indicated that those participants who read the clinical information
handbook scored 80 % higher on an assessment of knowledge about clinical trials than
the participants who did not read the handbook. That study also demonstrated that it is
important to consider re-educating the research participant about clinical trials if more
than two months have passed between reading the handbook and providing consent for
a trial. Therefore, it was postulated that the use of an educational handbook to
supplement informed consent about a specific trial may provide truly informed consent.
(Campbell et al. 2008.)
In another study, patient information leaflets were found to be a useful tool also for the
surgeon  to  improve  the  recall  of  the  information  given  to  the  patient,  in  order  to
facilitate informed consent (Ashraff et al. 2006). The preparation of a genetic
consultations booklet for cancer patients led to an increase in satisfaction with the
information provided, and to a decrease in the level of decisional conflict due to lack of
information. Even the increase of knowledge was marginal, the provision of the booklet
was found to encourage the patients to undergo the tests. (Mancini et al. 2006.)
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However, in everyday practice, evidence-based leaflets were not effective in promoting
informed choice in women using maternity services (O'Cathain et al. 2002). The same
conclusion was made in a literature review of the effectiveness of leaflets in promoting
informed choice in screening programmes. Therefore, it has been stated that screening
programmes should not rely on routine provision of information to ensure that
prospective users can make informed choices about participation. Even in cases where
such information has been specifically designed to promote informed choice, there is
little evidence that it actually achieves its goal. Therefore, the most effective way to
achieve informed choice in screening programmes is still unclear. (Fox 2006.)
The European Commission (2007) proposed the following strategies: participation of a
linguist for preparing the informed consent, interviews conducted among the
participants to ensure that they understand the issues at stake in the research project, and
presentation of the research project using information technologies (video, Powerpoint,
theatre play, etc.). Several research groups have examined the use of information
technology, for instance, an educational videotape can represent a useful tool for
informing the general public about the nature of cohort studies and these kinds of
videotapes may increase probable participation (Ishii & Ohashi 2007).
In addition, the use of computer-based visualization increased the satisfaction and
knowledge of patients and its presentation did not require significantly more time than
the standard paper-based conversation (Enzenhofer et al. 2004). The knowledge of
prenatal testing can also be increased by using a video, at least in principle. Moreover,
this can be done without making women more anxious, or more worried about fetal
abnormalities. (Hewison et al. 2001.) In one other study, the use of audiovisual patient
information was a useful addition to the consent process for randomized cancer trials in
terms of improving patient knowledge and understanding before decision making. It
appeared to reduce anxiety at this time point and was found to be an acceptable medium
for patients. The use of audiovisual patient information was not shown to have any
effect on refusal rates to randomized cancer trials. (Hutchison et al. 2007.)
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However, the evidence of a review was that the value of audio-visual interventions for
people considering participation in clinical trials was mixed with respect an individual’s
awareness of the trial they are considering entering, and/or the health condition the trial
is designed to address; one study showed improved retention of knowledge amongst
intervention recipients. The intervention may also have small positive effects on the
quality of information disclosed, and may increase willingness to participate in the
short-term; however again the evidence is weak. There were no data about several
primary outcomes, including harm. In the absence of clear results, it has been
recommended that researchers should continue to explore innovative methods of
providing information to potential trial participants. (Ryan et al. 2008.)
One further strategy to improve the provision of information is to use different types of
consent forms. In one study, the research group compared a standard, industry-designed
consent  form and  a  modified,  shortened  version  of  the  same form to  determine  which
would allow the patient with a history of asthma to retain more information in the
immediate post consent period. They concluded that patients retained more information
from the shortened version. (Dresden & Levitt 2001.) Another research group
concluded also that shorter information sheet with a test and feedback session should be
evaluated so that informed consent would become valid informed consent (Fortun et al.
2008).
A recent literature search did not identify any previous publications addressing the
direct impact of the type of consent required, and potential research subjects’
participation. The length and type of informed consent required affected potential
research subject participation in a survey research design. Participants who were asked
to sign a detailed written informed consent document had a lower rate of participation
compared to those asked either orally or with a brief written consent form. (Marco
2008.)
If one wishes to ensure that clinical research subjects are participating as well-informed
and willing partners it is crucial to have a better understanding of how literacy might
impact on comprehension of the information provided and how to best to address this
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issue (Raich, Plomer & Coyne 2001). For example, patients welcome evidence-based
information  and  are  able  to  utilize  it  to  make  an  informed  choice  e.g.  about  prostate-
specific-antigen screening. Concerns that evidence-based information may induce
anxiety or ‘fear’ about prostate cancer or would be perceived as biased against
screening appeared to be unwarranted. (Gattellari & Ward 2005, cf. Chan et al. 2003.)
When elderly patients were provided with a balanced discussion of the benefits,
burdens, and uncertainties of colorectal cancer screening this information did influence
their perception of screening effectiveness, but had no impact on their preference for
undergoing screening. This negative result does not diminish the importance of
involving elderly patients in decisions, but does suggest that factors other than
information must be more important in determining their interest in participating in
screening programmes. (Wolf & Schorling 2000.)
Although the majority of our participants felt that the information received was
sufficient, there were issues about which many of them felt they had insufficient
information. These were: selection criteria of the participants, possible benefits, and
negative effects, funding and reporting. It is noteworthy that these facts were provided
in the written information. In addition, the respondents wrote in open questions that they
needed more information about general matters related to this particular intervention
study and whether they would have access to their own results. An earlier study found
also that many participants were interested in receiving individual results rather than a
summary of the entire trial (Dixon-Woods et al. 2006, cf. MacNeil & Fernandez 2006).
According to the European Commission’s detailed guidance for ethics committees,
written information should be provided to subjects concerning any financial or other ties
to a sponsor, institutional affiliations of the investigators, and the name and address of
sponsors or sources of funding (European Commission 2004). Although disclosure of
investigators’ financial interests in research does not substantially affect willingness to
participate, potential research participants do attach some importance to this
information, for example, they are more troubled by equity interests than by per capita
payments intended to cover the costs of research. (Weinfurt et al. 2008b.) The results of
this thesis showed that about half of the respondents considered that receiving
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information on funding is important, almost third considered this information to be of
moderate importance, and nearly one third answered that this matter was not at all
important to the research participant.
In general, according to our findings, a higher educational level is related to a need for
more information. Nonetheless, we may ask the question of whether highly educated
persons  are  really  those  who  need  more  information  or  whether  they  are  used  to
receiving extensive information on topics affecting them personally. A particular
challenge  in  the  informed consent  process  for  clinical  trials  is  to  assess  the  beliefs  of
those  patients  or  participants,  who have  already  made  their  decision  about  whether  or
not to take part in the trial, before receiving any information or discussion about it. They
are often unwilling to even consider the information, an issue that is difficult to assess
in any research study. (Hutchison, Cowan & Paul 2007.)
In summary, perhaps nothing is changing more dramatically in health care than the
increased volume and influence of information. Patients and potential participants face a
growing need for assistance in knowledge management and for access to professionals
who are qualified this task. (Woolf et al. 2005.) It has been claimed that more research
is needed on what participants in clinical investigations want and need to know, and
how to convey this information in a format and in an environment that is conducive to
individualized decision-making (Raich, Plomer & Coyne 2001).
6.1.2 Understanding
The findings of this thesis support the proposal that the participants had understood
most of the information given in the exercise and diet intervention study. Nonetheless, it
is difficult to assess how well the participants have comprehended the information (e.g.
Sreenivasan 2003). For example, a signature on an informed consent document does not
guarantee that the individual has understood or appreciated what it means to be a
research subject in a clinical trial (Schwartz & Appelbaum 2008). Virtually every
bioethics text includes material on informed consent in general and more specifically on
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the ethics of human experimentation. However, both empirical reseach and bioethics
analyses tend to focus on the philosophical principles of autonomy and doing no harm,
rather than on the difficult practical problems of how to ensure comprehension and how
to assess voluntariness (Higgins & Daly 2002).
Information sheets for clinical research are becoming increasingly complex but the
extent to which they are understood is uncertain (Fortun et al. 2008). It has been stated
that for many patients or participants, issues of health care literacy, the language used in
the process, and the peoples’ ability to comprehend what is being presented, can lead to
a misperception of the true nature of research trials. (Naarden & Cissik 2006).
Therefore, there appears to be a clear need for empirical testing of methods and
instruments capable of increasing the participant’s intake and uptake of relevant
information (Rabin & Tabak 2006).
The literature describes different ways to improve understanding. These efforts are
somewhat similar to those intended to improve the dissemination of information. For
example, in order to enable comprehension and facilitate informed choices, the written
information about the research should be easy for the potential participants to read
(Coyne et al. 2003, Paasche-Orlow, Taylor & Brancati 2003, Franck & Winter 2004). It
has been shown that readability cannot be improved by adding lengthy explanations to a
consent form because this may undermine participants’ understanding of the research in
which they are being asked to take part (Shalowitz & Wendler 2006). In addition, the
European Commission (2007) recommends interviews conducted with the participants
to ensure that they have understood the issues at stake in the research project.
Techniques for improving subjects’ understanding of the research include giving a copy
of the informed consent form to the subject, viewing a videotape of the research
procedure, and calling subjects after they have signed the consent so that they can ask
questions or express concerns (Turner 2005). Using of a modified consent approach
(improving the readability and design of the consent form, reading the consent form to
participants in their native language, and using an iterative, teach-to-goal strategy), has
also been considered to improve the quality of informed consent also in lower literacy
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and minority status populations. One study showed that complete comprehension of
consent information could be achieved for 98 % of participants who engaged in this
improved consent process, including those with literacy and language barriers. (Sudore
et al. 2006.)
The readability and comprehensibility of a standard information leaflet can be also
improved by professional linguistic revision of the leaflet (Bjørn, Rossel & Holm 1999).
One ideal solution is to couple information with high-quality decision counselling to
help patients or participants understand the potential risks, benefits, and uncertainties of
clinical options etc. (Woolf et al. 2005). Given adequate support, research participants
can be helped to understand sufficiently well in order to enable them to give valid
consent. This support has been shown to improve understanding also in rare disease
research. (Parker et al. 2004.)
Many researchers agree that the use of informational videos may enhance the informed
consent process for clinical research (e.g. McLaughlin, Brindley & Crowther 2002,
Koren et al. 2003). However, a systematic review proved that above mentioned
procedures do not consistently improve research participants’ understanding. Instead,
face-to-face interactions, especially extended discussion interventions, may improve
understanding more effectively. But even if an informational video does not improve
understanding, at least all research participants in a study are exposed to the required
information. (Flory & Emanuel 2004.)
Another review came to the same conclusion that no method proved to be perfect in
terms of improving comprehension (Paris et al. 2007). For instance, two recent
strategies for improving the comprehension of research consent disclosures (graphically
enhanced consent form and meditation of the consent process by a third-party
facilitator) may not be effective. However, the understanding of consent disclosures
may be improved, at least in the short term, by providing iterative feedback to those
potential research participants who appear to be experiencing some initial difficulties
with comprehension. (Stiles et al. 2001.) In addition, extended discussion interventions
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seemed to be more effective than, for example, enhanced consent forms or multimedia
(Paris et al. 2007).
Even though the focus in this thesis is on volunteer adult research participants, the
viewpoint of patients cannot be overlooked. It has been reported that the actual
understanding of the clinical trial information by patients is rarely optimal (Hietanen et
al. 2007, cf. Denberg, Wong & Beattie 2005). In addition, there are currently no formal
practice guidelines from professional societies for the assessment of a patient’s capacity
to consent to treatment (Appelbaum 2007). Little is known also about patient
characteristics associated with comprehension at consent information, and whether
modifications to the consent process could promote understanding (Sudore et al. 2006).
Physicians have a duty to offer to their patients, of all ages, the opportunity to take part
in clinical trials and to ensure that research is appropriately designed and conducted.
However, special consideration should be given to ensure that patient consent is fully
informed and freely given. (Bayer & Fish 2003.) For example, participants in early-
phase clinical trials have reported high expectations of benefiting from their
participation. There is concern that many participants may misunderstand the trials to
which they have consented. Patients who express high expectations may not do so as
evidence of understanding but rather as a way of registering optimism. (Weinfurt et al.
2008a.) Therefore, the issues surrounding informed consent include readability of the
consent, educational level of participants, relationships with health care providers,
therapeutic misconceptions, and the severity of the illness (Steinke 2004).
Fortunately, there have been studies focusing on ways to improve patient understanding.
For example, one research group tested the effect of an easy-to-read informed consent
statement with participants in a cancer treatment trial. Patients in the intervention group
demonstrated significantly lower consent anxiety and higher satisfaction compared with
patients in the control arm. Patient comprehension and state anxiety were not affected
by the intervention. The study indicates that easy-to-read informed consent statements
are associated with reduced patient consent anxiety and increased satisfaction with the
informed consent document, but not with improved patient comprehension. It has been
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recommended that clinical trial informed consent statements should be modified to be
easier to read without omitting critical information. Patient anxiety and satisfaction can
be affected by the consent document. (Coyne et al. 2003.) In addition, the effects of
social  support  on  comprehension  and  recall  of  consent  form information  in  a  study  of
Parkinson disease patients and their caregivers showed that social support played a
significant role in enhancing comprehension and recall of consent form information
(Ford et al. 2008).
One study examined patients with psychotic disorders to clarify whether it would be
possible to improve understanding of research consent with this group of patients. The
participants were randomized to receive a routine consent or enhanced consent
procedure. Those who received an enhanced consent procedure displayed better
comprehension than those who received the routine consent procedure. Among the
patients, comprehension test scores correlated with level of education and cognitive
performance. The normal comparison subjects also seem to have benefited from the
enhanced consent procedure. The authors concluded that when a concerted effort was
made to impart crucial consent information, even older patients with chronic psychotic
disorders displayed improved post consent understanding. (Dunn et al. 2001, 2002.)
Elderly patients, in general, may encounter greater more difficulties comprehending
consent information and thus it is recommended that particular attention should be paid
to compensating for communication and sensory deficits, improving readability of
information sheets and consent forms as well as considering the use of innovative
consent procedures. (Bayer & Fish 2003.)
Some more examples are given; one research group evaluated the feasibility,
acceptability, and preliminary efficacy of two enhanced consent procedures provided to
patients with Alzheimer disease or mild cognitive impairment. The patients were
randomly assigned to an enhanced written consent procedure or a slideshow
presentation. The results showed that verbal re-explanation was associated with
improved understanding in both conditions. The level of understanding did not
significantly differ between the two consent groups, but the time needed for viewing the
slideshow presentation was less than that for an enhanced written consent procedure.
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Nonetheless, enhanced consent procedures seem to be a feasible and useful way for
obtaining consent in patients with mild cognitive impairment or mild Alzheimer
disease. (Mittal et al. 2007.) In addition, a decision aid booklet was noted to help
women in deciding about whether or not they would participate in a breast cancer trial.
The booklet was found to add to their understanding over and above the participant
information sheet and was not anxiety provoking. (Juraskova et al. 2008.)
Even though proper attention was paid in adhering to accepted ethical and legal
standards, it was noted that patient in a trial in acute myocardial infarction
comprehension was incomplete or even totally lacking in a considerable number of
subjects (Yuval et al. 2000). In addition, at present there is little information about
whether cardiac patients’ understand what is meant when they are asked to volunteer in
a clinical trial for drugs to treat unstable angina pectoris/non-Q-wave acute myocardial
infarction. One study explored prevalence, pattern, and determinants of patient
comprehension for investigations in this area and reported that significant determinants
of poor initial score were female sex, limited education, and the presence of pain during
the consent process. Young age was the only determinant of improvement with repeat
assessment. Thus initial understanding of the research protocols for trials in patients
with unstable angina pectoris or non-Q-wave acute myocardial infarction was imperfect,
especially with respect to the risk associated with participation. These workers
recommend that consent procedures (including information sheets) be brief, concise,
and designed to highlight potential benefits and risks, and differentiating between
standard and experimental modes of therapy. (Kucia & Horowitz 2000.)
In summary, it is critical that efforts should be made to increase subject understanding
in  current  biomedical  and  health  research.  The  provision  of  written  information  to
volunteers is one of the ways to address this issue. In most studies performed in healthy
volunteers, the written information is provided at the screening visit, at the same time as
the  oral  explanation.  However,  the  written  information  is  kept  by  the  subject  and
questions may arise before the randomization process. By that time, the subjects are
expected to have assimilated the information. (Paris et al. 2007.) In the exercise and diet
intervention study, written information was sent to the potential participants’ homes and
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handed them when they attended the screening visit when it was supplemented with
verbal instructions (see page 73).
The findings of this thesis indicated that the research participants’ comprehension of the
information received was adequate in 82 % of the whole study population. In addition,
higher education and satisfaction with personal health were statistically significantly
associated with adequate comprehension of received information. However, if one
considers the incorrect answers, 5 % of the population had not understand the purpose
of  the  study  in  question,  2  %  did  not  know  or  remember  the  purpose  of  the  study  in
which they were participating and 11 % gave no response to a question concerning the
purpose of the exercise and diet intervention study.
Understanding is a complex process based on both intelligibility of the text and the
subject’s ability to assimilate this information. Its assessment is complex and requires
validated questionnaires. Many factors can influence subject comprehension; one earlier
study showed that a medical or paramedical professional background as well as a high
school level was associated with increased comprehension. This same study showed
also that there is a significant interaction between the type of informed consent
document and gender with women having an increased comprehension score at baseline
compared with men. (Paris et al. 2007.)
In  addition,  lower  literacy  and  minority  status  have  been  shown to  be  associated  with
requiring more time to achieve complete comprehension of the consent process (Sudore
et al. 2006). Furthermore, lower educational level, mental illness, and perhaps advanced
age have been claimed to be associated with decreased understanding (Flory & Emanuel
2004). However, data of this thesis do not support these assumptions. For example,
there were no statistically significant associations between age, education or health care
professional background and opinions about intelligibility of the information given.
Despite increasing regulatory scrutiny, deficiencies still exist in participant
comprehension of the research in which they are being asked to participate, as well as
differences in how comprehension is measured and assessed. An integrative review of
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the literature indicated that no single intervention was identified as being consistently
successful for improving participant comprehension, though it does seem that a
successful consent process should at a minimum include various communication modes
and is likely to require one-to-one interaction with an individual who is knowledgeable
about the study. (Cohn & Larson 2007.) One interesting finding in the literature is that
there is a correlation between the respondents’ own assessment of the comprehensibility
of the form, and their actual comprehension. This indicates that it may be useful simply
to  ask  whether  or  not  a  prospective  research  subject  has  found the  information  leaflet
easy or difficult to understand. (Bjørn, Rossel & Holm 1999.) In this thesis the
participants were asked to give their own assessment of the comprehension of how
understandable they felt the information had been.
6.1.3 Competence
We estimated whether the participants in the exercise and diet intervention study were
competent to make a decision about participation and to understand what is included
and required. However, it has been claimed that there is no gold standard by which to
determine adequate decisional capacity (Dunn et al. 2002). In addition, it is difficult to
determine what the word “competence” actually means. According to the literature
review, very few of the empirical studies, for example, in the field of intensive and
critical care nursing offered any definitions or descriptions of the concept of
competence. (Ääri, Suominen & Leino-Kilpi 2008.)
In general, it is not possible to obtain informed consent if the person is very young,
severely ill, mentally impaired, demented or unconscious, or even frail or confused.
People often cannot give informed consent to their own emergency treatment. (O’Neill
2003.) Emergency medicine research also requires the enrolment of subject with
varying decision-making capacities, including capable adults, adults incapacitated by
illness or injury, and children (McRae & Weijer 2008). Mental inability to make
decisions on treatment is common in people admitted to psychiatric wards from the
community though this assumption has been questioned (Owen et al. 2008). For
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example, in one study a high percentage of particular vulnerable, mentally ill prisoners
showed adequate decisional capacity to consent to participation in research. Therefore,
it has been recommended that ethicists must continue to study and weigh the potential
vulnerability of special groups e.g. prisoners since it has been claimed that they have
become an overprotected population. (Moser et al. 2004, cf. Fisher et al 2006.)
It has stated that with today’s complex research protocols and increasingly sophisticated
and sometimes risky treatment options, when combined with an aging population at risk
of having cognitive impairment and therefore impaired decisional capacity, there is an
undeniable need for reliable and valid capacity assessment methods (Dunn et al. 2006).
In a study concerning assisted living residents, it was noted that the need to assess
decisional  capacity  of  all  potential  research  participants  who  are  members  of  a
population at high risk for cognitive impairment. The results of this study also
emphasize the importance of identifying an appropriate surrogate decision maker to
participate in the consent process for research focused on dementia or psychiatric
disorders and to provide proxy informed consent if needed. (Black et al. 2008.)
However, it is possible that by implementing best ethical practice including a formal
assessment  of  capacity  to  consent  to  a  research  project  in  an  acute  medical  ward  may
have resulted in a considerable reduction in the numbers of subjects willing to
participate  in  a  study.  Also,  patients  who enter  a  research  study  after  a  formal  test  of
capacity may be unrepresentative of all patients who might be recruited into a research
study.  In  other  words,  the  process  of  the  formal  assessment  may  itself  reduce  the
consent rate. (Adamis et al. 2005.)
Research involving healthy volunteers is less likely to cause ethical concerns. Since
these research participants are not ill and, more specifically, do not have a condition
with the potential to compromise decision-making capacity, there is no reason to
question their ability to provide informed consent. (Miller 2003.) It has stated that the
biggest thief of autonomy is sickness (Cassell 2005). In summary, the argument that the
participants in the exercise and diet intervention study were competent to make a
decision about participation is reinforced by previous publications. The participants
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were adult volunteers without any treatment association to the Kuopio Research
Institute  of  Exercise  Medicine.  We  have  no  ethical  reason  to  question  their  ability  or
competence to provide consent.
6.1.4 Voluntariness
Voluntarism  refers  to  the  capacity  to  make  a  choice  freely  and  in  the  absence  of
coercion (Roberts 2002). Our participants considered that they participated in the
exercise and diet intervention study of their own free will and without coercion.
However, a minority of the participants (5 %) were not aware of their right to withdraw
from  the  intervention  study  at  any  time.  The  right  to  withdraw  from  the  study  at  any
time might include passive withdrawal, such as the participant not returning study
materials. In such a case, the researcher must then carefully decide when to cease
follow-up procedures (Steinke 2004). In this Informed Consent Study, no questionnaire
was sent to those participants who failed to show up for his/her guidance visit or to any
participant  who refused  to  fill  in  the  questionnaire.  A related  issue  that  is  not  as  well
understood or studied is the collection and reporting data from potential participants
who refuse to take part when approached for consent. One argument is that researchers
are obligated to respect patient autonomy and confidentiality by refraining from
collecting data from patients who withhold permission. (Higgins & Daly 2002.)
Research ethics committees and institutional review bodies increasingly stipulate that
investigators refrain from repeated contact with potential participants, unless these
patients actively signal willingness to consider participation (the so called ‘opt-in’
approach). However, recruiting unbiased patient samples with high response rates is
vital for the scientific rigour of many types of medical research. The traditional means
of participant recruitment assumes that patients are potentially willing to participate, and
non-response to an initial approach can be followed up with a further communication
(the so called ‘opt-out’ approach). One research group showed that the opt-in approach
resulted in lower response rates and a biased sample. Therefore, they concluded that the
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opt-out approach should be the default recruitment strategy for studies with low risk to
participants. (Junghans et al. 2005.)
Another study (Baker et al. 2000) suggested that researchers should seek consent also if
data are to be collected from patient’s records, and allowances should be made for the
likely  magnitude  of  refusal  in  calculating  sample  sizes.  It  has  been  stated  that  if
researchers are to retain the trust of patients, individual consent should always be sought
first before collecting data from records. The only exception should be when a research
ethics committee has waived the requirement to seek consent for pressing and justifiable
reasons. Willison and co-workers (2003) concluded the same.
The results of a study concerning neurological emergency treatment trial did suggest
that it may be difficult to obtain truly informed consent even in a relatively simple and
straightforward trial. However, this study also showed that even in a study involving a
clinical situation perceived as life threatening, asking permission for study inclusion is
generally considered as acceptable. (Hofmeijer et al. 2007.) From elsewhere, a study
quantifying the influence of risk and discomfort or pain on patients’ willingness to
participate in clinical studies reported that the consent process protected patients,
although not for the anticipated reason. Understanding was poor, but patients who failed
to understand the risks or discomforts rarely consented to participate and those patients
who felt pressured did not consent. Consequently, relatively few patients unknowingly
agreed to participate in risky or painful studies. In contrast, patients who understood the
risks involved were twice as likely to consent. In addition, many patients have been
shown to be willing to participate in risky or painful studies, apparently for altruistic
reasons. (Treschan et al. 2003.) It has been claimed that a balance between ‘opt-in’ ‘opt-
out’ approaches can perhaps be achieved by giving a limited amount of accurate and
relevant information and providing user friendly ways as well as easy ways of
rescinding consent once given (O’Neill 2003).
In conclusion, a major determinant of willingness to participate appears to be an
individual’s trust in medical research and researchers (Weinfurt et al. 2008b). In
addition, one finding from this thesis is that ‘helping other people’ is an important factor
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contributing to willingness to participate in a research project. Earlier studies have come
to the same conclusion. For instance, when asked the positive reasons for joining a trial
in women with a high familial  risk of breast  cancer,  40 % of women on the trial  cited
‘helping future generations’ (Lovegrove et al. 2000).
6.1.5 Decision-making
In our exercise and diet intervention study the participants estimated that the decision-
making concerning participation had been voluntary. In addition, the participants
considered that sufficient time given for considering participation. It has been
emphasized that potential participants need time to read the information in peace and
think about it before discussing it again with the researchers. Thus, if nobody refuses to
take part in a study, one may speculate whether participation entirely has been
voluntary. For example, recruitment may have been too persuasive or refusal made too
difficult. (Vähäkangas 2004.) One study concerning genetic testing showed that
providing adequate time to consider whether or not to be tested and giving more support
to  patients  after  testing  could  also  be  considered  to  promote  the  rights  of  patients
(Nyrhinen et al. 2009). Therefore, it has been recommended that patients and potential
participants should be encouraged to take enough time to understand all available
options in order that they may make informed decisions (Yoder 2006).
According to the majority of the respondents, the researcher (doctor), research nurse and
research personnel were persons who are able to affect their decision-making
concerning participation. When asked what factors had affected their participation, one
important opinion was that there was a moral duty for people to volunteer: willingness
to help other people and advancement of knowledge. This result is similar to the results
of Russell and co-workers (2000). In addition, other reasons have been given e.g. a
prisoner stated that participating was a way to avoid boredom, others liked to meet
someone new, or wished to appear to be cooperative in hopes of being treated better,
and helping society (Moser et al. 2004).
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These findings can be generalized when voluntary research participants are investigated.
However in clinical research, the situation is quite different. Emotions, such as hope and
desperation, frequently motivate people to participate in a clinical trial. For example, it
has been reported the despair can predispose patients and their families to make
decisions based on unrealistic hopes (Chen, Miller & Rosenstein 2003). Expectations of
being treated as ‘a special patient’ in a trial are important in convincing subjects to
participate (Madsen et al. 2000).
In  another  report,  it  was  stated  that  if  the  patient  is  in  a  critical  clinical  condition  and
there is an absence of a patient representative at the critical time period then it may be
difficult and sometimes impossible to receive informed consent before the beginning of
the  trial.  However,  not  requesting  consent  before  a  trial  is  also  contradictory.  (Halila
2007.) Despite this fact, an earlier study revealed that an appreciable proportion of
patients undergoing surgery for acute abdominal conditions were aware that they
retained the ability to give informed consent for surgery. Nonetheless, informed consent
prior to urgent surgery is perceived to be less comprehensive than for elective
procedures. (Kay & Siriwardena 2001.) In addition, one challenging group is
participants and their parents in paediatric clinical research (Chappuy et al. 2006).
The use of financial compensation as a recruitment tool in medical research continues to
be debated on ethical grounds (Dunn & Gordon 2005). Various methods have been used
to compensate research participants, and these can influence participation. Researchers
must carefully determine what compensation, if any, is provided and the amount of
compensation, and develop strategies to avoid possible coercion (Steinke 2004). One
systematic review of the literature revealed that financial rewards were important
motivator among normal healthy volunteers in their decision to participate in clinical
trials (Tishler & Bartholomae 2002). In Finland, the law prohibits researchers from
paying compensation to research participants. However, the participants can be
compensated for the use of their time, travelling expenses, loss of earnings and other
inconveniences (cf. Dickert, Emanuel & Grady 2002).
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An  amount  of  money  that  is  not  excessive  and  is  calculated  on  the  basis  of  time  or
contribution may, rather than constituting an inappropriate inducement, be an indication
to the participant about how much time their contribution to the research may entail
(Grady 2001).  Even  though there  are  no  financial  rewards  many people  are  willing  to
participate in research projects, fortunately. Some earlier studies have come to the same
conclusion. For example, in the work of Russel and co-workers, the majority of the
respondents were opposed to payment of research subjects, regardless of whether the
subjects were healthy volunteers or patients (Russell, Moralejo & Burgess 2000).
In the exercise and diet intervention study most participants felt that informed consent
had been confirmed and verified well. The participants had given their written consent
for participation. In the literature there is considerable discussion about the actual
implications of the written consent form. For example, discussion about the fact that
institutions and professionals increasingly view informed consent as some kind of
protection against accusations, litigation and compensation claims. Hence, informed
consent has become “the modern clinical ritual of trust”. (O’Neill 2003.) On the other
hand, there is the opinion that the informed consent form is only a stand-in for the
process of informed consent itself and that greater attention should be paid to the
professional-participant interaction in the process of informed consent in research with
less  reliance  placed  on  the  signed  consent  form  as  evidence  of  adequate  informed
consent (Kahn & Mastroianni 2001). It has been claimed that for informed consent to be
adequate, then it should represent a systematic educational process rather than a mere
ethical form or procedure (Matsui, Kita & Ueshima 2005).
There have been discussions also about waiving informed consent, for example, in the
quality-improvement studies. It has proven that it is often impossible to obtain informed
consent from patients enrolled in quality-improvement research programs because
interventions must routinely be adopted for entire hospitals or hospital units. Therefore,
it has been stated that it is justifiable from an ethical and a regulatory perspective to
waive informed consent for low-risk research when soliciting consent is not practicable
and consent would not provide any meaningful protection to the subjects. (Miller &
Emanuel 2008.) My opinion is still that written consent is essential and in addition,
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informed consent should be a process which continues through the whole research
project. However, the concerns posed above are valid.
In summary, it has been claimed that informed choice is a complex concept that
depends on more than knowledge alone (Kellar et al. 2008). Nonetheless, the discussion
about the decision-making process still revolves around the topic of adequate
information. For example, the use of educational DVD increased cancer patient
knowledge and satisfaction regarding participation in phase I clinical trials and
enhanced the decision-making process (Strevel et al. 2007). Furthermore, providing
men with information about screening for prostate cancer enabled them to assume a
more active role in decision-making with their family physician, and this resulted in a
lower level of anxiety and decisional conflicts. In other words, providing the
participants with information enables them to make informed screening decisions with
their physicians. (Davison et al. 1999.) In addition, to improve decision-making, the
research team should not only ensure full disclosure, but determine that the information
has been understood and assimilated (Rabin & Tabak 2006). In this thesis, the majority
of participants were satisfied with information they received. Therefore, it is concluded
that decision-making was based on a voluntary informed choice.
6.2  Enhancing the informed consent process
The literature review as well as the discussion of this thesis indicated how much effort
has been expended on enhancing the informed consent process. However, even though
there is widespread agreement on the importance of informed consent in clinical
research, uncertainty remains about the adequacy of current consent procedures and
documentation. Many studies have failed to provide evidence that they have adhered to
effective informed consent procedures. For example, Guarino and co-workers (2006)
concluded that making the consent document more consumer-friendly did not lead to
either benefit or harm in understanding, satisfaction, or study refusal and adherence
rates. However, they demonstrated that embedding consent studies in a clinical trial is
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feasible and can address important questions about informed consent without disrupting
the primary study.
One aspect of enhancing the informed consent process is the effectiveness of ethical
review. The European Union directive provides a workable recommendation for an
effective ethical review. Despite European legislation to harmonize procedures for
ethical approval, it has claimed that the rules and regulations need to be better
standardized and implemented in order to improve harmonization, especially in
multicenter trials. It has also noted that obtaining approval for multinational studies is
still complex and time consuming. (Schnitzbauer et al. 2009.) There are also concerns
that legislation on privacy may unduly bias observational studies using medical records.
Therefore, ethical review boards need to give thoughtful decisions on whether the need
for mandatory consent is necessary. (Kho et al. 2009.) However, these kinds of studies
are outside the scope of this thesis.
The  Declaration  of  Helsinki  and  the  WMA’s  International  Code  of  Ethics  contain  the
crucial statement that a physician’s or investigator’s conscience and ethical duty must
transcend national laws. Thus simply being compliant with national laws that respect
basic human rights and ethical norms is a necessity, but is not in itself a sufficient
standard. However, the Food and Drug Administration (FDA) of the United States (US)
has ruled that clinical trials performed outside the US no longer have to conform to the
Declaration of Helsinki if used to support applications for registration of products in the
US. (Goodyear et al. 2009.) This is one signal that reforms are needed (cf. Fost &
Levine 2007).
The crucial ethical challenge is to balance risks and benefits in the context of the needs
and capacities of individual research subjects. Thus, it is important that the Institutional
Review Board (IRB) system must become evidence-based and not rely on unproven
assumptions. In addition, the contexts of medical practice and of research changed so
dramatically in the last quarter of the twentieth century. Over and above IRB’s uniform
rules about informed consent, there are many still outstanding issues, including
coercion, explaining randomization and alternative treatments to subjects, the role of
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physicians as investigators, and informed consent for special populations that have not
been standardized to any great extent at the institutional level. Relative little attention
has been given to whether there should be a special type of consent process for longer-
term studies. In particular, if there is a long maintenance schedule (e.g. 2–3 years in
duration) and consideration could be given to asking the subject for consent again at the
end of each year of the maintenance phase. (Frank, Novic & Kupfer 2003.)
The large-scale randomized trial by Lavori and co-workers (2007) demonstrated that it
is possible to design and conduct randomized studies of innovations in the informed
consent, in the context of real clinical studies, without interfering with the parent
studies, and at a modest cost. That study underlined the need to evaluate rigorously
(with validated experimental methods) any suggested changes to the informed consent
process that may be advanced by those interested in ensuring the valid informed consent
of participants.  They also recommended that it  might be useful to examine the current
consent processes that have grown by accretion of plausible but untested procedures and
requirements. For example, an anonymous telephone interview immediately after the
consent process, conducted by an independent interviewer not affiliated with the parent
study is more likely obtain an unbiased assessment of the consent process than a face-
to-face interview by a study team member. Despite belief to the contrary, a standardized
quality assurance tool, for instance, did not enhance informed consent in actual clinical
trials. (Lavori, Wilt & Sugarman 2007.)
One should not overlook the educational aspects when attempting to improve the
informed consent process (e.g. Fletcher et al. 2007, Khalil et al. 2007). For example, it
has been reported that a short communication skills course for physicians and nurses
engaged in a clinical trial about disclosing patient information improved the quality of
informed consent and patient satisfaction and therefore, it may be advantageous to
include this kind of training in the clinical trial planning process (Hietanen et al. 2007).
In addition, surgical trainees’ knowledge of informed consent for bedside procedures
has been shown to be enhanced by an educational program. The training programme did
improve their knowledge but not the practice of obtaining consent. Thus, it was
concluded that providing instructions about the consent process concomitantly with
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technical training may increase awareness and success in obtaining informed consent
for  bedside  procedures.  (Steinemann  et  al.  2006.)  However,  when  the  impact  of  a
communication skills training workshop targeting specific doctor behaviours during a
cancer clinical trial consultation were evaluated, no differences were obtained between
the pre- and post-training groups. Nonetheless, a short training programme did achieve
limited success in improving the oncologist’s communication skills in gaining informed
consent. (Brown et al. 2007.)
In summary, more research is needed to rigorously evaluate proposed methods to
enhance informed consent prior to any widespread adoption (Lavori, Wilt & Sugarman
2007). In addition, discussion about the ethical issues involved between different
interested parties is essential. Discussion allows for the weighing of different arguments
and makes it possible to form balanced and reasoned decisions. The citizens in Finland
are becoming increasingly aware of their rights. A vigorous on-going debate is needed
in order to make health care more ethically acceptable, particularly in today’s world
where there is absolute no good or evil, but most often a compromise between these two
polarities. (Halila 2003.)
6.3  Validity and reliability
Validity is a complex idea that is important to the researcher and to those who read the
study report and consider using the findings in their practice. Validity represents a
major foundation for making decisions about which findings are useful for patient care.
(Burns & Grove 2001.) The validity of this thesis can be viewed in terms of its external
validity. External validity is concerned with the extent to which the study findings can
be generalized beyond the sample used in the study. The significance of the study
depends on the number of types of people and situations to which the findings can be
applied. (Burns & Grove 2001, McDowell 2006.) The DR’s EXTRA Study is a
randomized controlled intervention trial in which a representative 15 % sample of the
population was invited to participate as the target population. Therefore, the results of
this study can apply probably to older people, at least in Finland.
96
It has been discussed about whether participation in a randomized controlled trial (RCT)
increases a participant’s (especially patients) risk of a bad outcome, or that the results of
RCT’s are not applicable to usual clinical practice. However, a systematic review
concluded that participants in the RCTs had similar outcomes to comparable patients
who received the same or similar treatment outside the trial. Therefore, it seems that the
results of RCTs are applicable to comparable patients, for example, those receiving
usual clinical practice. (Vist et al. 2005.)
The internal validity of this thesis can be considered by selection. That topic addresses
the process by which subjects are chosen to take part in a study and how subjects are
grouped within a study. For example, people assigned to the control group could be
different in some important way from people allocated to the experimental group. This
difference in selection could cause the two groups to react differently to the treatment.
(Burns & Grove 2001, McDowell 2006.) Again, the DR’s EXTRA study is a
population-based intervention trial and the participants were randomized into six
intervention groups. This procedure avoided the possibility of allowing the participants
to select the intervention group they would have preferred.
In this Informed Consent Study the sample size was large (n=1329) which added to the
validity of the research. Since the validity of the statistical evaluation decreases if
statistical power is low. A low statistical power increases the probability of concluding
that there is no significant difference between samples when actually there is a
difference (Type II error). A Type II error is most likely to occur when the sample size
is small. (Burns & Grove 2001, McDowell 2006.)
In this thesis, content-related validity evidence was obtained from the literature, content
experts, and representatives of the relevant populations. Content validity is the extent to
which the method of measurement includes all the major elements relevant to the
construct being measured (Campbell & Machin 1993, Burns & Grove 2001, Everitt &
Palmer 2005, McDowell 2006). The content of the questionnaire was based on the
relevant literature about informed consent. The questionnaire was developed
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collaboratively through critical discussion within a multidisciplinary expert group. To
improve the validity and reliability of the questionnaire, a pilot study was conducted;
and subsequently a new pre-test (with written instructions) was evaluated with five
people chosen to simulate the actual participants. In addition, a representative 15 %
sample of the target population was invited to participate in the DR’s EXTRA Study.
If one wishes to obtain reliable results then it is essential to employ an appropriate
research design (Altman 1999). The reliability of a measure denotes the consistency of
measures  obtained  in  the  use  of  a  particular  instrument.  For  example,  if  the  same
measurement scale is administered to the same individuals at two different times, the
measurement is reliable if the individuals’ responses to the items remain the same
(assuming that nothing has occurred to change their responses). (Burns & Grove 2001,
Everitt & Palmer 2005, McDowell 2006.) One limitation of this thesis is that measure of
the reliability was not pre-arranged.
To ensure the validity and reliability of data analyses, a statistical expert was used as a
consultant. Statistics can contribute to good research by pointing to the optimum way to
analyze the results (Campbell & Machin 1993). In addition, the variables used in
logistic regression model (individualized research question two) were also classified
into three classes: poor (1-2), moderate (3) and good (4-5). The intention was to check if
this classification would change the results. There was only a difference between the
two  and  three  classes  division  in  one  comparison:  the  purpose  of  the  study  and
confirming of understanding. This correlation showed statistically significant
association when two classes were used (p=0.03), but not when the results were
subdivided into three classes (p=0.09). This difference was considered insignificant in
our estimation of the overall validity of the results of the study.
One significant factor is the high response rate (91 %) of this Informed Consent Study
which increases both the validity and reliability of this research. The participants
received the questionnaire, written instructions and verbal directions personally during
the three-month intervention visit. This gave them an opportunity to pose any questions
at the same time, which probably contributed to the high response rate. The response
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rate to questionnaires is generally lower than that with other forms of self-reporting,
particularly if the questionnaires are mailed out. If the response rate is lower than 50%,
the representativeness of the sample must seriously be questioned. (Burns & Grove
2001.)
6.4  Study Limitations
This thesis has several limitations. First, the main limitation of the Informed Consent
Study was that the questionnaire is new and has not been used by other research groups.
However, this questionnaire has a sound foundation on recent legislation, regulations
and literature. In the 21st century, the research ethics guidelines have been overhauled
and are now better defined. Therefore, there was a need to create a questionnaire which
would take into account recent literature concentrating on voluntary research
participants who have no treatment connections with the research institute or
researchers. In addition, many of standardized questionnaires for evaluating the quality
of informed consent are either focused on or have been developed for the
hospital/patient  context.  For  example,  the  QuIC  (Quality  of  Informed  Consent
questionnaire by Joffe and co-workers) was developed and pre-tested in a population of
cancer clinical trial participants and, therefore, its wording is cancer-specific. The
authors emphasize that differences between cancer and non-cancer clinical trials means
that the QuIC should not be used in a non-cancer setting until it is verified as being
valid. (Joffe et al. 2001a, 2001b, Barrett 2005, Hietanen et al. 2007.)
Due to the novelty of this Informed Consent questionnaire, it was developed and tested
very carefully. This process is described in detail in pages 56–58. It should be taken into
account that this questionnaire was developed, pre-tested and used in a population of
‘healthy’ adult volunteers. Nonetheless, since there may be differences between
volunteers and patient in clinical trials we recommend that our questionnaire should be
re-tested before further use.
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Second, this questionnaire does not address in sufficient depth several aspects of
understanding and competence. However, evidence from this thesis is that it is
extremely  difficult  to  evaluate  how  much  a  participant  really  understands  the
information he/she received, and whether the participant is competent to comprehend its
meaning.
Third,  this  study  does  not  provide  information  on  how  to  define  the  optimal  point  of
time to conduct an interview or inquiry for investigation of informed consent.
According to the findings, this questionnaire was appropriate, at least over the short
term,  for  the  research  in  question.  The  data  were  collected  after  three  months  of
participation  in  the  exercise  and  diet  intervention  study.  The  opinion  was  that  after  a
few months, the participants will have a better idea about the intervention study than
immediately after randomization. On the other hand, the period of time was so short that
the recall of the participants was still strong. However, when the participants were asked
where they obtained first information about the exercise and diet intervention study,
over 30 % did not remember this correctly. For example, a fifth of the respondents
remembered that they had seen an announcement, some of respondents thought that
they had been invited through a previous study, a few remembered that they had first
obtained information from a friend. In actual fact, the participants had each received an
invitation through the post telling them about the exercise and diet intervention study.
The period between sending the letter and the baseline survey was, on average, two
years.
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7  CONCLUSIONS
This thesis adds empirical knowledge about obtaining informed consent in health
research from the point of view of volunteer adult research participants. In addition, this
thesis reveals that it is possible to examine and measure the extent of realization of
informed consent by means of a questionnaire. On the grounds of this study it can be
estimate  that  the  exercise  and  diet  intervention  study  (DR’s  EXTRA  Study)  was
conducted with and adhered to high ethical standards with respect to the informed
consent process.
Based on the results of this thesis, implementation and success in intervention are linked
to  whether  subjects  receive  a  sufficient  amount  of  information  which  they  are  able  to
comprehend and in this way can provide truly informed consent. However, this thesis
highlights objectively how difficult it is to disseminate information even to voluntary
adult participants. Therefore, this study identifies the need for all health-related
researchers to critically analyze the quality and manner in the way that information is
provided. This is especially important in long-term follow-up studies. Based on the
results of this thesis, special efforts should be made with participants with lower
educational levels or subjective feelings of impaired health.
One further aim is that all members of the research and study group view informed
consent as a continuous process to be considered through the whole duration of the
project. In addition, further study efforts should be focuced on improving the ways that
potential research participants are made aware and ensuring that they have understood
the informed consent process for example by studying how participants’ understanding
of the research process could be improved. One important question is: ‘How can we be
sure that research participants really understand the information they receive?’
Although, 100 % comprehension is probably unachievable, it should nonetheless be the
goal.
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Recommendations based on this thesis:
1 In all studies, a random sample of participants should be given a questionnaire
which is concerned with informed consent. This kind of enquiry will provide
important information about the participants’ true knowledge and satisfaction
concerning the research project in which they are participating.
2 The standard should be adopted that every research participant is asked to
describe in their own words the purpose of the study in which they are
participating. This will ensure that they have an adequate grasp and understanding
of the information provided.
3 The  results  of  this  thesis  showed  that  those  subjects  who  felt  themselves  to  be
healthier were more likely still to be participating in the intervention study at the
2-year intervention. Therefore, it is not enough to inquire about possible medical
information of the participants. It is important to simply ask how the participants
view their own health.
Fortunately, people are still willing to participate in scientific research – for this
scientists should be thankful. This apparently originates from people’s trust in science,
research and researchers. However, this trust should not and cannot be taken for
granted. We can maintain people’s confidence in science only if all professionals
honour a commitment to ethical principles, such as those enshrined in the principal of
‘Informed Consent’.
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Author(s) Purpose, Sample, Method and Main findings and conclusions
Adamis,
Martin,
Treloar,
et al.
(2005)
UK
Purpose: To investigate whether different methods of obtaining informed
consent affected recruitment to a study of delirium in older, medically ill
hospital inpatients.
Sample: All  patients  (n=130)  70  years  or  older  admitted  to  the  unit  between
Nov 2000 and Jan 2001 for acute assessment, directly from home or other
wards if this was within three days of admission to hospital.
Method: Randomized into two groups: a) a formal test of capacity, followed by
either  a  request  for  consent  or  an  attempt  at  obtaining  assent  from  a  proxy
(n=57, mean age 83.4 years, SD 6.1, men 47.4 %), or b) a combined informal
capacity/consent process (n=73, mean age 83.8 years, SD 6.8, men 41.1 %).
Main finding and conclusions: Using the formal method of assessing capacity
and obtaining consent excluded more patients overall and also led to fewer
people with case note delirium being recruited. Thus, a stringent assessment of
capacity may exclude patients with delirium from studies, thus rendering
findings less generalizable and predispose to sample bias.
Baker,
Shiels,
Stevenson,
et al.
(2000)
UK
Purpose: To investigate what proportion of patients refuse consent to data
collection from their records for research purpose.
Sample: n=3429, age: 16 or above. Random samples of patients with either
asthma or stabile angina in 81 volunteer practices.
Method: Questionnaires that included a request for consent to collect data from
the patient’s clinical records was sent to randomized patients.
Main finding and conclusions: There were no significant differences between
patients who consented and those who did not for mean age, sex, severity of
symptoms or satisfaction with care. Researchers should seek consent if data are
to be collected from patient’s records, and allowances should be made for the
likely magnitude of refusal in calculating sample sizes.
Bjørn,
Rossel,
Holm.
(1999)
Denmark
Purpose: To study whether linguistic analysis and changes in information
leaflets can improve readability and understanding.
Sample: Two different groups (n=235): a) testing of a new drug for
hypertension (n=135, mean age 74 years, median range 62-92, male 34) , b) the
effect of a new local anaesthetic in connection with the sterilisation of women
(n=100, mean age 35, 25-45).
Method: Two information leaflets concerning trials of drugs for
conditions/diseases which are commonly known were modified, and the
original was tested against the revised version.
Main finding and conclusions: The perception of the readability and
comprehensibility of a standard information leaflet can be improved by
professional linguistic revision of the leaflet.
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Author(s) Purpose, Sample, Method and Main findings and conclusions
Black,
Brandt,
Rabins,
et al.
(2008)
USA
Purpose: To identify factors associated with providing either informed consent
or assent for research in individuals at high risk for cognitive impairment.
Sample: A stratified random sample of 198 assisted living residents (mean age
85.7  years,  SD  8.25,  male  21  %)  participated  in  the  study  from  22  assisted
living facilities.
Method: Residents’ consent or assent status was documented as providing
informed consent, written assent, or verbal assent/no objection.
Main finding and conclusions: Residents were more likely to provide written
assent or verbal assent/no objection than informed consent at enrolment. The
relatively small proportion of participants who could provide informed consent
highlights the importance of assessing decisional capacity for research in a
high-risk population and identifying an appropriate surrogate decision maker to
provide proxy consent if needed.
Brown,
Butow,
Boyle,
et al.
(2007)
Australia
Purpose: To evaluate the impact of a communication skills training workshop
targeting specific doctor behaviours during a cancer clinical trial consultation.
Sample: Oncologists (n=10, mean age 42.7 years, range 35-40, male 6) and
their adult cancer patient (n=90, mean age 55 years, range 33-84, male 32 %)
who where eligible for a Phase II or Phase III clinical trial.
Method: Informed consent consultations were audiotaped before (n=59) and
after (n=31) training.
Main finding and conclusions: There were no differences between the pre-
and post-training groups. Thus, this short training programme demonstrated
limited success in improving the oncologist’s communication skills when
gaining informed consent.
Campbell,
Raisch,
Sather,
et al.
(2008)
Mexico
Purpose: To study the impact of a clinical trials information handbook on
patient knowledge, perceptions, and likelihood of participation.
Sample: Randomized controlled trial from the outpatient clinic waiting areas
(18 years or older). The control group (n=62) and the intervention group
(n=84).
Method: Intervention group read the information handbook then immediately
answered a questionnaire. The control group completed the questionnaire
without reading the handbook. In addition, retained knowledge was assessed
between 6 and 12 weeks through follow-up phone interviews to subgroup of
intervention group participants.
Main finding and conclusions: The  participants  who  read  a  clinical
information handbook scored 80 % higher on an assessment of knowledge
about clinical trials than participants who did not read the handbook. Use of an
educational handbook to supplement informed consent of a specific trial may
provide truly informed consent.
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Author(s) Purpose, Sample, Method and Main findings and conclusions
Cohn,
Larson
(2007)
USA
Purpose: To critically analyze studies published within the past decade about
participants’ comprehension of informed consent in clinical research and to
identify promising intervention strategies.
Design: Integrative review of literature.
Method: Studies published between Jan 1996 and Jan 2007.
Main finding and conclusions: Of the 980 studies identified, 23 met the
inclusion criteria. Interventions tested included simplified written consent
documents, multimedia approaches, and the use of a trained professional to
assist in the consent process. Collectively, no single intervention strategy was
consistently associated with improved comprehension.
Coyne,
Xu,
Raich,
et al.
(2003)
USA
Purpose: To test the effect of an easy-to-read informed consent statement with
participants in a cancer treatment trial.
Sample: Randomized controlled trial in 44 institutions. Total of 207 patients
participated either in the control group (n=129, mean age 53 years, male 9.3 %)
or in the intervention group (n=78, mean age 53 years, male 7.7 %).
Method: Telephone interviews (approximately 1 to 2 weeks later) were
conducted to assess study outcomes.
Main finding and conclusions: This study indicates that easy-to-read informed
consent statements are associated with reduced patient consent anxiety, an
increased satisfaction with the informed consent document, but not with
improved patient comprehension.
Davison,
Kirk,
Degner,
et al.
(1999)
Canada
Purpose: To determine if providing men with information about screening for
prostate cancer would enable them to assume a more active role in decision-
making with their family physician, and lower level of anxiety and decisional
conflicts.
Sample: Men (n=100) recruited from one family medical clinic. Randomized in
intervention (n=50, mean age 60.7 years, 8.6) and control (n=50, mean age 63.6
years, SD 8.0) groups.
Method: Men in intervention group were asked what they knew about
screening for prostate cancer. They were then provided with both verbal and
written information. Men were encouraged to discuss screening issues with
their family physician and participate in making a screening decision.
Main finding and conclusions: Men who received the information prior to the
periodic health examination (PHE) assumed a significantly more active role in
making a screening decision, and had lower levels of decisional conflict post
PHE. The groups did not differ with regard to levels of state anxiety. Providing
men with information enables them to make informed screening decisions with
their family physicians.
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Dobscha,
Corson,
Solodky,
et al.
(2005)
USA
Purpose: To describe the effects of using videoconferencing on participant
enrolment, research measure administration and responses, study retention, and
satisfaction.
Sample: Patients  from  primary  care  clinics  who  were  recruited  for  a
randomized clinical trial of a care management intervention for depression
(n=400). This article discusses a subgroup (n=31) who were interviewed using
videoconference.
Method: Initial interview or interview using videoconferencing and mail
survey regarding the interview.
Main finding and conclusions: There were no significant problems with the
process of interviewing and obtaining informed consent by videoconference.
No differences were observed between depression scores of videoconference
and in-person participants, and there was no significant difference in the 6-
month rate of loss to follow-up in the randomized trial. In conclusion,
videoconference allows patients in rural and remote locations to participate in
psychiatric research and expands sources of recruitment for research projects.
Donovan,
Mills,
Smith,
et al.
(2002)
UK
Purpose: To improve design and conduct of randomized trials by embedding
them in qualitative research.
Sample: Controversal ProtecT (prostate testing for cancer and treatment) trial
embedding within qualitative research. Men aged 50-59.
Method: In-depth interviews explored interpretation of study information.
Audiotape recordings of recruitment appointments. Findings were used to
determine changes to content and presentation of information.
Main finding and conclusions: Changes in the content and delivery of study
information increased recruitment rates from 40% to 70%. The embedding of
randomized controlled trials in qualitative research may enable even the most
difficult evaluative questions to be tackled and could have substantial impacts
on recruitment to apparently routine trials.
Dresden,
Levitt.
(2001)
USA
Purpose: To compare a standard, industry consent form (IF) and a modified,
shortened version of the same form (MF) which allows the patient to retain
more information in the immediate post consent period.
Sample: 100 patients with a history of asthma were randomized to IF (n=50)
and MF (n=50) groups. Mean age 39.4 years (SD 12.1), male 48 %.
Method: After reading the consent form, the patients were given a post consent
test to determine how much information was retained.
Main finding and conclusions: Compared with an industry consent form, a
shortened version allowed patients to retain more information in the immediate
post consent period.
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Dunlop,
Graham,
Leroy,
et al.
(2007)
USA
Purpose: To examine the impact of infusion of Health Insurance Portability
and Accountability Act (HIPAA) authorization on the willingness to participate
in a clinical research study and explore reasons for nonparticipation.
Sample: 384 African American outpatients at 4 metropolitan primary care
clinics.
Method: Interviewees were randomly assigned to undergo informed consent
alone (control group, n=192) or informed consent with HIPAA authorisation
(HIPAA group, n=192). They were asked whether they would participate and
reasons for their decisions.
Main finding and conclusions: A smaller proportion of interviewees in the
HIPAA group were willing to enrol in the study. In conclusion, the infusion of
HIPAA authorization within the informed consent process may adversely affect
the willingness of African American to participate in clinical research and may
raise concerns about privacy, understanding the forms, and mistrust or fear of
research.
Dunn,
Lindamer,
Palmer,
et al.
(2002)
USA
Purpose: To improve understanding of research consent in patients with
psychotic disorders.
Sample: 80 outpatients with schizophrenia or related psychotic disorders and
19 normal comparison subjects, ranging in age from 40 to 80.
Method: Participants were randomized to receive a routine consent (41
patients, 10 comparison subjects) or enhanced consent (39 patients, 9
comparison subjects) procedure. A comprehension test was administered after
the consent procedure.
Main finding and conclusions: Those who received enhanced consent
procedure (EC) had better comprehension than those who received routine
consent procedure (RC). EC patients did not differ significantly from RC
normal comparison subjects in their post-test scores. Among the patients,
comprehension test scores correlated with level of education and cognitive
performance. Normal comparison subjects also seem to have benefited from the
EC procedure.
Dunn,
Lindamer,
Palmer,
et al.
(2001)
USA
Purpose: To examine whether a novel consent procedure improve the
comprehension of consent for older patients with psychosis.
Sample: 80 outpatients with schizophrenia or related psychotic disorders and
19 normal comparison subjects, ranging in age from 40 to 80.
Method: Participants were randomized to receive a routine consent (41
patients, 10 comparison subjects) or enhanced consent (39 patients, 9
comparison subjects) procedure. A comprehension test was administered after
the consent procedure.
Main finding and conclusions: A significantly greater proportion of patients
who received the enhanced consent procedure scored 100 % on first and second
trials  of  the  post-test,  compared  to  those  receiving  the  routine  procedure.  In
conclusion, the enhanced consent method improved comprehension of
information relevant for consent in older patients with psychosis.
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Dunn,
Nowrangi,
Palmer,
et al.
(2006)
USA
Purpose: To critically review existing measures of decisional capacity for
research and treatment.
Sample: 23 decisional capacity assessment instruments.
Method: Articles from 1980 to 2004 describing structured assessments of
adults’ capacity to consent to clinical treatment or research protocols.
Main finding and conclusions: 10 instruments focused on consent in research
protocols, 15 on consent to treatment and 2 were used in both contexts. The
instruments focused mostly on the understanding component of decisional
capacity. Those who work in the field of capacity assessment need to develop
consensus on the appropriate definitions and standards for measuring each
domain.
Fortun,
West,
Chalkley,
et al.
(2008)
UK
Purpose: To  assess  recall  by  healthy  volunteers  of  key  facts  in  a  patient
information sheet in a phase 3 clinical trial.
Sample: Healthy volunteers (n=82) participating in a capsule endoscopy study.
Method: A 13 page written information sheet were given and allowed to ask
questions. After participants indicated being ready to give consent they were
asked to complete a questionnaire covering the identity and adverse effects of
trial treatments and of the procedure, the duration of the trial and value of the
inconvenience allowance.
Main finding and conclusions: A comprehensive information sheet resulted in
limited recall  of  trial  risks.  Shorter  information sheet  with a  test  and feedback
session should be trialed so that informed consent becomes valid informed
consent.
Fox
(2006)
UK
Purpose: Review studies of the effectiveness of leaflets in promoting informed
choice in screening.
Sample: 9 studies from 264 identified articles.
Method: A critical literature review.
Main finding and conclusions: Most studies demonstrated that providing
written information increased knowledge, but evidence that this promoted
informed choice was poor. In conclusion, the most effective way for screening
programmes to achieve informed choice is unclear.
Garfein,
Swartzen-
druber,
Ouellet,
et al.
(2007)
USA
Purpose: Explore methods to recruit and retain a cohort of young-adult
injection drug users for the research of HIV/HCV (hepatitis C virus) prevention
trial.
Sample: New injection drug users (IDU) who were HIV and HCV antibody
negative at baseline (n=857, mean age 23.8 years, male 69 %).
Method: Interview at baseline and follow-up assessment at 3 and 6 months
post-intervention.
Main finding and conclusions: Recruitment and retention of young-adult
IDUs for complex intervention trials is complicated, yet feasible.
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Gattellari,
Ward.
(2005)
Ausralia
Purpose: To compare the impact of 3 information resources about prostate-
specific-antigen (PSA) screening: a leaflet, a video and an evidence-based
booklet.
Sample: 421 men (aged between 50 and 70) recruited from the community.
Method: 140 received a leaflet, 141 a video and 140 an evidence-based
booklet. Computer-assisted telephone pre-test and post-test surveys.
Main finding and conclusions: Men in all three groups demonstrated
significant increases in knowledge scores from pre to post-test. Scores were
significantly higher among those who had received evidence-based booklet
compared with men who received the leaflet or video.
Hack,
Whelan,
Olivotto,
et al.
(2007)
Canada
Purpose: To compare two audiotape formats for the delivery of information
relevant to informed consent to participate in a clinical trial in breast oncology.
Sample: 69 women with newly diagnosed breast cancer and 21 oncologists
from 5 Canadian cancer centres.
Method: Patients were randomized to three groups: standardize audiotape,
consultation audiotape or both audiotapes. Patients received their audiotapes
immediately following the clinical trial consultation.
Main finding and conclusions: There were no differences in clinical trial
knowledge or perception of being informed across the intervention groups.
Patients tended to prefer receiving an audiotape of their own consultation over a
standardized audiotape. The majority of oncologists considered the audiotape
intervention feasible.
Hewison,
Cuckle,
Baillie,
et al.
(2001)
UK
Purpose: To assess the effect of a Down syndrome screening video on test
uptake, knowledge and psychological stress.
Sample: 2000 women referred for antenatal care.
Method: Women were allocated to two equal groups: one to be sent a video to
their home, before their hospital booking visit (n=993), and a control group
(n=1007). A subset of 1200 women was selected to be posted at 17-19 weeks’
gestation a questionnaire to assess the psychological endpoints.
Main finding and conclusions: The video had no effect on the screening
uptake rate. Knowledge of screening was increased in the video group with a
statistically significant difference. There were no significant differences
between the groups in specific worries about abnormalities in the baby, and
general anxiety. In conclusion, a video can increase knowledge without
affecting the uptake of the test, or psychological stress.
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Hietanen,
Aro,
Holli,
et al.
(2007)
Finland
Purpose: To investigate whether a short course in communication skills for
physicians would improve the quality of informed consent in a randomized
clinical adjuvant trial on breast cancer.
Sample: Patients participating in a breast cancer trial (n=288): intervention
group (n=149, mean age 50.6) and control group (n=139, mean age 50.2).
Method: Physicians and research nurses attended a one-day communication
skills course. The quality of informed consent was evaluated by addressing a
standardized questionnaire to trial patients at involving hospitals.
Main finding and conclusions: The patients of the intervention group were
significantly more satisfied with the information received and the time given to
make their decision. They also understood the main aim of the study better and
recalled more often that the physician had also offered other therapeutic
options. In conclusion, a short communication skills course for the trial
physicians and nurses improved the quality of informed consent and patient
satisfaction in the trial.
Hofmeijer,
Amelink,
Hertog,
et al.
(2007)
Netherlands
Purpose: To study differences in recall of information and in appreciation of
the informed consent procedure between representatives included in two
controlled trials testing treatment strategy.
Sample: Representatives in the Hemicraniectomy After Middle cerebral artery
infarction with Life-threatening Edema Trial (HAMLET) (n=28) and
representatives of patients participating in the randomized trial of Paracetamol
In Stroke (PAIS) (n=30).
Method: Recall of trial details and appreciation of the informed consent
procedure were interviewed, one year after study inclusion, using a
questionnaire and compared between the two groups.
Main finding and conclusions: HAMLET representatives remembered
statistically significantly more trial details. With respect to appreciation of the
informed consent procedure, there were no differences between the groups. In
conclusion, recall of trial details is lower in a trial in which less vital issues are
at stake.
Hutchison,
Cowan,
McMahon,
et al.
(2007)
UK
Purpose: To determine the effect of an audiovisual patient information (AVPI)
intervention on refusal rates to randomized cancer trials, knowledge and
anxiety, and to investigate patients’ perceptions of the AVPI.
Sample: 173 colorectal, breast or lung cancer patients were randomized to
receive either the AVPI in addition to the standard trial-specific written
information (n=86, male 23.3 %), or the written information alone (n=87, male
23 %).
Method: Data were collected by questionnaire at hospital visit of patients’
general medical care.
Main finding and conclusions: The AVPI had no effect on refusal rates to the
randomized cancer trials. It did have a positive effect on levels of knowledge
about  clinical  trails.  It  also  reduced  anxiety.  In  addition,  the  AVPI  was
perceived by patients to be a useful adjunct to the informed consent process.
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Ishii,
Ohashi.
(2007)
Japan
Purpose: To examine whether an educational videotape might change peoples’
attitudes toward participating in future cohort studies.
Sample: The participants (n=255) were recruited at a health promotion festival
(n=139), a nursery care study class (n=54), an elderly class (n=53), and
individuals who had not attended a health check-up for more than 10 years
(n=9).
Method: All participants were randomized into a control group and an
intervention group (a videotape), and were asked to fill out a questionnaire.
Main finding and conclusions: The educational videotape intervention
showed a statistically significant positive attitude to future participation. In
conclusion, the videotape provided to be a useful tool for informing the general
public about the nature of cohort studies and to increasing probable
participation.
Juraskova,
Butow,
Lopez,
et al.
(2008)
Australia
Purpose: To pilot a decision aid (DA) booklet for a high priority breast cancer
prevention trial (IBIS-II DCIS).
Sample: 31 women participating in the IBIS-I breast cancer prevention trial.
Method: Participants read the information sheet and the DA booklet,
completed a standardized questionnaire and provided feedback on the DA via a
semi-structured phone interview.
Main finding and conclusions: Women found the DA helpful in deciding
about trial participation, reporting that it aided their understanding over and
above the approved information sheet and was not anxiety provoking.
Kellar,
Sutton,
Griffin,
et al.
(2008)
UK
Purpose: To evaluate an innovative invitation to increase informed choice in
relation to screening for type 2 diabetes.
Sample: Volunteer members of the public (n=417) aged between 40 and 69
years, with no previous diagnosis of diabetes.
Method: Participants were randomized to receive one of two hypothetical
invitations for screening for type 2 diabetes: traditional invitation (n=139, male
50.4%) and informed choice invitation (n=278, male 45.3 %). Informed choice
was assessed immediately after the invitation (n=417, male 47 %) and 2 weeks
later using a questionnaire (n=407).
Main finding and conclusions: Compared with the traditional invitation, the
informed choice invitation resulted in a significantly higher proportion of
informed choice. This increase reflected increased type 2 diabetes screening-
related knowledge but not increased attitude-intention congruence.
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Kruse,
Kjaergard,
Krogsgaard,
et al.
(2000)
Denmark
Purpose: To examine how three types of written information influence
outpatients’ knowledge about and attitude toward research and randomized
clinical trials (RCTs).
Sample: 415 outpatients 18 years or over.
Method: The patients were randomized to the following groups: control (n=89,
mean age 48 years, SD 18, male 32), leaflet (n=94, mean age 50 years, SD 20,
male 38), brochure (n=96, mean age 46 years, SD 19, male 39), or booklet
(n=90, mean age 45 years, SD 19, male 38). These formats differed in length,
reading ease, and reader appeal. Data were collected by structured
questionnaires at entry and 2 weeks after intervention.
Main finding and conclusions: Written information about general aspects of
RCTs improved knowledge about and attitude towards RCTs. Elaborate
information rather than brief information was more effective.
Kucia,
Horowitz.
(2000)
Australia
Purpose: To explore patients’ understanding of clinical trials in unstable
angina pectoris (UAP) / non-Q-wave acute myocardial infarction (NQAMI)
Sample: 20 patients, mean age 66.7 years, SD 10.5, male 60 %.
Method: Subjects were interviewed twice with the same questionnaire: at 10
(+/-4) and 24 (+/-3) hours after randomization to index clinical trial.
Main finding and conclusions: Significant determinants of poor initial score
were female sex, limited education, and presence of pain during the consent
process; young age was the only determinant of improvement on repeat
assessment.
Lavori,
Wilt,
Sugarman.
(2007)
USA
Purpose: Test the cumulative effect of a quality assurance questionnaire
intended to enhance awareness in the person obtaining informed consent on the
quality of the informed consent in clinical trials.
Sample: 836 research subjects from five participating randomized clinical
trials: HOST (n=11, mean age 73 years, SD 8.2, male 100 %), RadArt (n=45,
mean age 62 years, SD 8.8, male 100%), SELECT (n=297, mean age 60 years,
SD 6.7, male 100 %), ThlNRS (n=373, mean age 67 years, SD 10.3, male 98
%), and WPTSD (n=110, mean age 44 years, SD 9.1, female 100 %).
Method: Either uses a new quality assurance questionnaire after each informed
consent encounter or the standard process of obtaining informed consent. The
quality of informed consent was evaluated using independent telephone
interviews.
Main finding and conclusions: The quality assurance questionnaire does not
provide an appreciable effect on the quality of informed consent. In conclusion,
despite prior beliefs, a standardized quality assurance tool does not enhance
informed consent in actual clinical trials. Future research is needed to
rigorously evaluate proposed methods to enhance informed consent prior to
widespread introduction.
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Lovegrove,
Rumsey,
Harcourt,
et al.
(2000)
UK
Purpose: To identify measurable differences between women who elect to join
a placebo-controlled, double-blind randomized trial of the drug tamoxifen and
women who elect not to join.
Sample: 106 participants (women not on the trial: n=53, mean age 45.8 years,
SD 9.9 and women on the trial: n=53, mean age 51 years, SD 8.1).
Method: Questionnaires covering demographic details, health locus of control,
perception of risk and adequacy of medical communication.
Main finding and conclusions: Only half of the sample elected to join. The
significant findings were that the women who elected not to join the trial were
younger and aware of significantly more lifestyle factors that predispose to the
development of breast cancer.
Lynöe,
Näsström,
Sandlund.
(2004)
Sweden
Purpose: To elucidate the quality of information provided to patients who
participated in a clinical trial of a lipid-lowering remedy.
Sample: Patients (n=44) on hemodialysis or in a prerenal state (34 males, mean
age 67.8 years, range 39-82, and 10 females, mean age 67.3 years, range 44-82)
who had included in the clinical study over a 1-year period.
Method: Questionnaire concerning different aspects of the information
provided.
Main finding and conclusions: Compared to younger patients, elderly patients
tended to be informed about the trial only orally and were also inclined to let
the doctor decide whether or not they should participate. In conclusion,
providing information both orally and writing and providing sufficient time for
consideration may improve the informed consent process for severely ill
patients.
Mancini,
Noguès
Adenis,
et al.
(2006)
France
Purpose: To assess the impact of a standardized patient information booklet on
decisions women make about genetic testing.
Sample: The control group (n=263, mean age 49.1 years, SD 10.8) and the
experimental group (n=297, mean age 50.3 years , SD 11.2).
Method: Questionnaire completed at home within one month.
Main finding and conclusions: The booklet led to an increase in satisfaction
with the information provided, and to a decrease in the level of decisional
conflict due to lack of information. The increase of knowledge was marginal.
The booklet was found to strengthen patients’ decision to undergo the tests.
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Marco.
(2008)
USA
Purpose: To measure potential research subjects’ participation in a survey
research design, based on level and type of informed consent required before
enrolment.
Sample: 300 eligible Emergency Department participants (mean age 40 years,
range 18-83, male 39%) were randomized to one of three groups: verbal
consent (n=100), limited written consent (n=100), and detailed written consent
with signature (n=100).
Method: Patient satisfaction survey.
Main finding and conclusions: Participants who were asked to sign a detailed
written informed consent document had a lower rate of participation compared
to those with verbal or limited written consent.
Mittal,
Palmer,
Dunn,
et al.
(2007)
USA
Purpose: To evaluate the feasibility, acceptability, and preliminary efficacy of
two enhanced consent procedures provided to patients with Alzheimer disease
(AD) or mild cognitive impairment (MCI).
Sample: 35 consecutively referred patients with possible or probable mild AD
(n=19) or MCI (n=16). The mean age was 75.6 (SD 7.8) years, male 57.1%.
Method: Patients randomly assigned to an enhanced written consent procedure
or slideshow presentation (PowerPoint) were assessed with the MacArthur
Competence Assessment Tool for Clinical Research.
Main finding and conclusions: Verbal reexplanation was associated with
improved understanding in both conditions. Level of understanding did not
significantly differ between the two consent groups, but administration time for
slideshow presentation was less than that for an enhanced written consent
procedure. In conclusion, enhanced consent procedures are feasible and useful
for consent to research among patients with mild cognitive impairment or mild
Alzheimer disease.
Moser,
Arndt,
Kanz,
et al.
(2004)
USA
Purpose: To assess decisional capacity and susceptibility to coercion in prison
research subjects.
Sample: Subjects were 30 mentally ill prisoners in a medium-security facility
(mean age 31.9 years, SD 9.84, men 26, mean education 12.1, SD 1.84) and 30
healthy controls recruited advertisement and word of mouth (26 men, 4 women,
mean age 30.0 years, SD 11.46, mean education 12.7 years, SD 0.94).
Method: The groups were compared on ability to provide informed consent to
a hypothetical drug trial, susceptibility to possible coercion, neuropsychological
functioning, and psychiatric symptoms. Used assessment tools: The MacArthur
Competence Assessment Tool for Clinical research and self developed
questionnaire: the Iowa Coercion Questionnaire.
Main finding and conclusions: A very high percentage of these prisoners
demonstrated adequate capacity to consent to research. Prisoners performed in a
quantitative measure of decisional capacity significantly worse scores.
Regarding possible coercion, prisoners’ main reason for participating in
research included avoiding boredom, meeting someone new, appearing
cooperative in hopes of being treated better, and helping society. In conclusion,
ethicists will need to consider the possibility that prisoners have become an
overprotected population.
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Paris,
Chaves,
Cornu,
et al.
(2007)
France
Purpose: To identify whether a working group, a systematic improvement in
lexico-syntactic readability or their association can improve the comprehension
of the written information given to volunteers in biomedical research.
Sample: Subjects (n=200) in four clinical research centres (ages from 18 to 45
years) were randomized to one of four groups: unchanged informed consent
form  (n=50,  mean  age  27.4  years,  SD  7.5,  male  26),  informed  consent  form
with systematic lexico-syntactic readability (n=50, mean age 28.2 years, SD
8.3, male 17), informed consent form modified by a working group (n=50,
mean age 26.5 years , SD 7.4, male 23), and informed consent form modified
by the working group followed by systematic lexico-syntactic improvement
(n=50, mean age 26.4 years, SD 6.6, male 19).
Method: Volunteers read the informed consent form and answered orally what
they had understood with own words (answers were recorded). Then they
completed  a  questionnaire.  About  5  weeks  later,  they  were  sent  the  same
questionnaire again.
Main finding and conclusions: Improving the informed consent document in
phase I biomedical research leads to better comprehension, whether the method
used is systematic lexico-syntactic improvement or a review by a working
group.
Peduzzi,
Guarino,
Donta,
et al.
(2002)
USA
Purpose: To compare the utility of an informed consent document developed
by a focus group of Gulf War veterans (focus group-developed) to an informed
consent document developed by the standard process involving the study
investigators (investigator-developed). Design paper.
Sample: Focus group: five Gulf War veterans.
Method: Veterans convened at the coordinating centre and developed a consent
document during three sessions. The focus group used the investigator-
developed consent document as a ‘starting point’ and then modified it by
consensus agreement.
Main finding and conclusions: Veterans were willing to participate in this
process and believed that their input could make a difference in the design of
informed consent documents in future trials.
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Ryan,
Prictor,
McLaughlin,
et al.
(2008)
Australia
Purpose: To assess the effects of providing audio-visual information alone, or
in conjunction with standard forms of information provision, to potential
clinical trial participants in the informed consent process, in terms of their
satisfaction, understanding and recall of information about the study, level of
anxiety and their decision whether or not to participate.
Method: Review. Selection criteria: randomized and quasi-randomized
controlled trials comparing audio-visual information alone, or in conjunction
with standard forms of information provision, with standard forms of
information provision alone, in the informed consent process for clinical trials.
Trials involved individuals or their guardians asked to participate in a real
clinical study.
Main finding and conclusions: Four trials involving data from 511 people.
Studies were set in the USA and Canada. Their quality was mixed and results
should be interpreted with caution. In conclusion, the value of audio-visual
interventions for people considering participating in clinical trials remains
unclear.
Stiles,
Poythress,
Hall,
et al.
(2001)
USA
Purpose: To evaluate alternative procedures for improving the understanding
of research consent disclosures by person who have mental illness.
Sample: 241 participants aged 18 years or older: persons with schizophrenia
(n=79, male 69 %), persons with depression (n=82, male 61 %), and a healthy
control group (n=80, male 61 %).
Method: The participants were guided through an informed consent process in
which two factors were manipulated. One was the structure of the disclosure
form; either a typical disclosure form involving standard dense text was used,
or a graphically enhanced form was used. The other was interpersonal process:
the presence or absence of a third-party facilitator, with iterative feedback given
to participants for whom a facilitator was not present. Assessed with the recall
tests.
Main finding and conclusions: Neither the graphically enhanced consent
disclosure form nor presence of a third-party facilitator was associated with
improved understanding. The use of iterative feedback was associated with
improvement in comprehension scores in all groups.
Strevel,
Newman,
Pond,
et al.
(2007)
Canada
Purpose: To assess an educational DVD’s impact on knowledge and
satisfaction in cancer patients newly referred to a phase I clinic.
Sample: 49 patients (mean age 56.3 years, SD 12.1, male 30) and 8 physicians
at a single institution.
Method: Patients were randomly to view an educational DVD (n=22) which
explained  phase  I  trials  or  a  placebo  DVD  (n=27).  Patients  completed  a
questionnaire assessing knowledge of phase I studies and satisfaction with the
DVD. The blinded interviewing physician rated the patient’s understanding of
phase I trials.
Main finding and conclusions: An educational DVD increased patient
knowledge and satisfaction regarding participation in phase I clinical trials.
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Sudore,
Landefelt,
Williams,
et al.
(2006)
USA
Purpose: To describe a modified research consent process, and determine
whether literacy and demographic characteristics are associated with
understanding consent information.
Sample: 204 ethnically diverse subjects (male 96, female 108), mean aged 61
years and 40 % had limited literacy. Exclusion criteria: if they had dementia,
were deaf, delirious, or not well enough to complete the interview.
Method: A modified consent process: consent form read to participants,
combined with 7 comprehension questions and targeted education, repeated
until comprehension achieved.
Main finding and conclusions: 28 % of subjects answered all comprehension
questions correctly on the first pass. Lower literacy and minority status were
associated with requiring more passes through the consent process.
Treschan,
Scheck,
Kober,
et al.
(2003)
Austria
Purpose: To evaluate the influence of protocol risk or discomfort and pain on
patients’ willingness to participate in clinical trials.
Sample: Patients (n=148) who were scheduled to undergo minor surgery with
general anaesthesia.
Method: Presented one of three sham protocol: no risk of pain (Control, n=47,
mean age 47, +/- 13 years, men 55 %), pain but no risk (Pain, n=51, mean age
51, +/- 16 years, men 41 %), or risk but no pain (Risk, n=50, mean age 49, +/-
15 years, men 38 %). Patients were debriefed at the end of the interview.
Main finding and conclusions: Understanding was poor, but patients who
failed to understand the risks or discomforts rarely consented. Patients who felt
pressured did not consent. Relatively few patients unknowingly agreed to
participate in risky or painful studies. In contrast, patients who understand the
risks involved were twice as likely to consent. Thus, patients are willing to
participate in risky or painful studies, apparently for altruistic reasons.
Weinfurt,
Hall,
Friedman,
et al.
(2008)
UK
Purpose: To examine the effects of the disclosure of financial interests in a
research consent process with patients recruited as they might have been for an
actual clinical trial.
Sample: 470 adults diagnosed with coronary artery disease.
Method: A telephone survey were participants randomly assigned to receive a
simulated informed consent document: per capita payments to the research
institution (n=160, mean age 66.7 years, SD 11.5, male 116), equity ownership
by the investigator (n=169, mean age 66.8 years, SD 10.4, male 130) or no
disclosure (n=141, mean age 67.1 years, SD 11.6, male 101).
Main finding and conclusions: Although disclosure of investigators’ financial
interests in research does not substantially affect willingness to participate,
potential research participants attach some importance to this information, and
they are more troubled by equity interests than by per capita payments that
cover  the  costs  of  research.  A  far  grater  determinant  of  willingness  to
participate appears to be people’s trust in medical research and researchers.
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Westberg,
Duchek,
Sandlund,
et al.
(2004)
Sweden
Purpose: To study whether or not the provision of written information in
advance might influence patients’ inclination to participate in the clinical
education of medical students at a urology surgery.
Sample: 42 outpatients referred to the urology surgery.
Method: Participants were randomly allocated either to receive information in
advance (n=19, mean age 60.3 years, male 16) or not (n=23, mean age 60.4
years, male 19). The doctors/teachers nor the students knew in advance to
which group a certain patient had been allocated. At the end of visit the patients
were asked to complete a questionnaire.
Main finding and conclusions: The provision of information in advance does
not negatively influence patients’ inclination to participate in the clinical
training of medical students.
Wirshing,
Sergi,
Mintz.
(2005)
USA
Purpose: To evaluate a brief educational video designed to enhance the
informed consent process for people with serious mental and medical illnesses
who are considering participating in treatment research.
Sample: 83 participants: Schizophrenia patients (mean age 37.2 years ,SD 13.9,
men 82 %), medical patients without self-reported comorbid psychiatric illness
(mean age 59.1 years, SD 12.9, men 82 %) and university undergraduates
without obvious medical, cognitive, or psychiatric problems (mean age 21.4
years, SD 7.2, men 40 %)
Method: Participants were randomly assigned to view either a highly
structured instructional videotape about the consent process in treatment
research or a control videotape that presented only general information about
bioethical issues in human research. Knowledge about informed consent was
measured by questionnaire before and after viewing.
Main finding and conclusions: The videotape was an effective teaching tool
across diverse population, ranging from individuals with severe chronic mental
illness to university students.
Wolf,
Schorling.
(2000)
USA
Purpose: To assess the impact of informed consent on elderly patients’
colorectal cancer (CRC) screening preferences.
Sample: 399 elderly patients visiting their primary care provider for routine
office visit.
Method: Patients were randomized to receive a scripted control message
briefly describing CRC screening method (n=133, mean age 75 years, SD 6,
male 38 %), informational intervention described CRC mortality risk reduction
in  relative  terms  (n=130,  mean  age  74  years,  SD  6,  male  37  %),  or
informational intervention described CRC mortality risk reduction in absolute
terms (n=136, mean age 74 years, SD 6, male 35 %)
Main finding and conclusions: Provision of information had no impact on
patients’ preferences for screening.
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Yuval,
Halon,
Merdler,
et al.
(2000)
Israel
Purpose: To examine the perspective of the Israeli patient cohort who
participated in the Fourth International Study of Infarct Survival (ISIS-4), a
randomized trial acute myocardial infarction.
Sample: 150 participants.
Method: A patient questionnaire was mailed. Main outcome measures included
patient perception of consent procedures, comprehension of the study,
subjective reaction to participating in the trial, and interest in present and future
trials.
Main finding and conclusions: Despite proper attention to accepted ethical
and legal standards, perceived patient comprehension in this trial in acute
myocardial infarction was incompetence or lacking in a considerable number of
subjects. Much progress must be made toward the goal of true informed consent
in clinical trials.
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Kuopion liikuntalääketieteen TIEDOTE TUTKITTAVALLE
tutkimuslaitos
30.06.2005/hla
ARVOISA VASTAANOTTAJA
Olette mukana Kuopion liikuntalääketieteen tutkimuslaitoksen liikunta- ja
ruokavaliotutkimuksessa (DR’s EXTRA). Pyrimme toteuttamaan
tutkimusprojektit mahdollisimman hyvin ja tästä syystä haluamme selvittää
kuinka tutkimukseen liittyvistä asioista tiedottaminen, ohjaus sekä käytännön
järjestelyt ovat toteutuneet Teidän kohdallanne. Näitä asioita selvitämme
kyselylomakkeella. Tämä osatutkimus toteutetaan Kuopion liikuntalääketieteen
tutkimuslaitoksen, Kuopion yliopiston hoitotieteen laitoksen ja Kuopion
yliopistollisen sairaalan kliinisen fysiologian osaston yhteistyöprojektina.
Pyydän Teitä täyttämään oheisen kyselylomakkeen ja palauttamaan sen
mukana olevassa kuoressa Kuopion liikuntalääketieteen tutkimus-
laitokselle. Postimaksu on maksettu puolestanne. Toivon Teidän
vastaavan kahden (2) viikon kuluessa lomakkeen saannista lukien.
Kaikki vastaukset käsitellään nimettöminä ja luottamuksellisesti. Teidän
osallistuminen on vapaaehtoista ja kieltäytyminen ei vaikuta Teidän
mahdollisuuksiin jatkossa osallistua erilaisiin tutkimushankkeisiin.
Yhteistyöstä kiittäen,
Helena Länsimies-Antikainen
Terveystieteiden maisteri / sairaanhoitaja, tutkija
Kuopion liikuntalääketieteen tutkimuslaitos
Haapaniementie 16, 70100 Kuopio
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DR’s EXTRA    KYSELYLOMAKE 
     
     tarra 
 
 
 
OHJEET VASTAAJALLE 
 
Tämän kyselylomakkeen kysymykset koskevat suurimmalta osin nyt meneillään olevaa 
liikunta- ja ruokavaliotutkimusta (DR’s EXTRA). Liittäkää vastauksenne tähän kyseiseen 
tutkimukseen, ellei kysymyksessä toisin mainita. Kyselylomake jaetaan jokaiselle 
tutkimushenkilölle kolmen kuukauden käynnillä. 
 
Lukekaa jokainen kysymys huolellisesti ennen vastaamista. Kysymyksiin vastataan 
ympyröimällä sopiva vaihtoehto tai kirjoittamalla kysytty tieto sitä varten varattuun tilaan. 
Jos joudutte korjaamaan jotain vastaustanne, vetäkää virheellinen merkintä yli. Kirjallisissa 
kysymyksissä kirjoittakaa tarvittaessa sekin, jos Teillä ei ole kysymykseen mielipidettä.  
 
Vastausaikaa Teillä on kaksi (2) viikkoa lomakkeen saannista lukien. Mikäli koette johonkin 
kysymykseen vastaamisen vaikeaksi, voitte kysyä neuvoa soittamalla Kuopion 
liikuntalääketieteen tutkimuslaitokselle (puhelin: 017- 288 44 77 tai 288 44 22 / Helena 
Länsimies-Antikainen). 
 
 
Täyttöpäivämäärä _____ / _____ 200___  
 
I OSA: TAUSTATIEDOT 
 
1. Sukupuoli 
 
1 Mies 
2 Nainen 
 
2. Ikä (vuosina):  ________ 
 
3. Siviilisääty 
 
1 Avioliitto tai avioliittoa vastaava (avoliitto) 
2 Naimaton  
3 Eronnut tai asumusero 
4 Leski 
  
 © Helena Länsimies-Antikainen (30.6.2005) 2(10) 
  
4. Asuinalue 
 
1 Kaupungissa keskustassa tai muussa taajamassa 
2 Kaupungissa keskustan tai taajaman ulkopuolella 
3 Maaseudulla kirkonkylässä, asutuskeskuksessa tai muussa taajamassa 
4 Maaseudulla kirkonkylän, asutuskeskuksen tai taajaman ulkopuolella 
 
5. Ammattikoulutus 
 
1 Ei ammattikoulutusta 
2 Ammattikoulutason tutkinto tai ammattikurssi 
3 Opistotasoinen ammatillinen tutkinto (myös amk) 
4 Yliopistotasoinen tutkinto 
5 Muu, mikä _________________________________________________________ 
 
6. Työtilanne 
 
1 Työssä 
2 Työtön 
3 Eläkkeellä 
4 Sairauslomalla 
5 Päätoiminen opiskelija 
6 Kotiäiti tai –isä 
7 Muu, mikä _________________________________________________________ 
 
7. Millaiseksi koette terveydentilanne tällä hetkellä? 
 
1 Erittäin huonoksi 
2 Huonoksi 
3 Kohtuulliseksi 
4 Hyväksi 
5 Erittäin hyväksi 
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8. Oletteko itse tai onko joku perheenjäsenenne terveydenhuoltoalan ammattilainen? 
 
1 Olen itse 
2 Perheenjäseneni on, kuka _____________________________________________ 
3 En ole, eikä perheenjäseneni ole 
 
9. Oletteko ennen DR’s EXTRA tutkimusprojektia osallistunut tutkimushenkilönä 
tutkimusprojektiin?  
 
1 Kyllä 
9.1.a. Kuinka monta kertaa (älkää laskeko DR’s EXTRA tutkimusprojektia 
mukaan)? ___________________________________________________________ 
9.1.b. Milloin DR’S EXTRAa edellinen tutkimusprojekti loppui Teidän osaltanne? 
___________________________________________________________ (kk/vuosi)  
2 En 
 
 
II OSA: TUTKIMUKSEEN SUOSTUMISEN EDELLYTYKSIÄ 
 
10. Mistä/keneltä saitte tiedon DR’s EXTRA tutkimusprojektista ensimmäisen kerran? 
Valitkaa vain yksi vaihtoehto. 
 
1 Lehti-ilmoituksesta 
2 Työpaikalta tiedotteesta (esim. ilmoitustaululta) 
3 Työtoverilta 
4 Sukulaiselta / omaiselta 
5 Tuttavalta 
6 Harrastuksen kautta 
7 Tutkimuslaitoksen henkilökuntaan kuuluvan yhteydenotosta 
8 Edellisen tutkimusprojektin kautta  
9 Sairaalasta hoitajalta / lääkäriltä (ympyröikää kumpi kyseisistä henkilöistä) 
10 Työterveydenhuollosta terveydenhoitajalta / lääkäriltä (ympyröikää kumpi 
kyseisistä henkilöistä) 
11 Muualta, mistä ____________________________________________________ 
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11. Kenen Kuopion liikuntalääketieteen tutkimuslaitoksen ammattihenkilön kanssa 
keskustelitte DR’s EXTRA tutkimusprojektista ensimmäisen kerran?  
  
1 Lääkärin 
2 Hoitajan 
3 Sihteerin / toimistotyöntekijän 
4 Muun, kenen _______________________________________________________ 
 
12. Millä tavoin kävitte ensimmäisen kerran keskustelua edellisessä kysymyksessä 
mainitun henkilön kanssa?  
 
1 Puhelimessa 
2 Henkilökohtaisella tapaamisella 
3 Muuten, miten ______________________________________________________ 
 
13. Ovatko Teillä tiedossa DR’s EXTRA tutkimusprojektin vastuuhenkilöt? 
 
1 Kyllä 
2 Ei  
 
14. Oletteko saanut tarvittaessa yhteyden DR’s EXTRA tutkimusprojektin 
yhdyshenkilöön tai henkilökuntaan? 
 
1 Kyllä 
2 En 
3 Minulla ei tähän mennessä ole ollut tarvetta ottaa yhteyttä 
 
15. Kuka on tähän mennessä huolehtinut DR’s EXTRA tutkimusprojektissa 
ajanvaraukset, yhteydenotot ym. käytännön asiat? 
 
1 Lääkäri 
2 Hoitaja 
3 Sihteeri / toimistotyöntekijä 
4 Muu, kuka _________________________________________________________ 
5 Ei kukaan tietty, vaan aina eri henkilö 
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Seuraavasta kysymyksestä eteenpäin aina lomakkeen loppuun asti on joukossa 
kysymyksiä, joissa pyydetään arvioimaan eri asioita asteikolla 1–5. 1=huonoin vaihtoehto 
ja 5=paras vaihtoehto. Ympyröikää kunkin kysymyksen kohdalla vain yksi Teille 
sopivimmalta tuntuva vaihtoehto.   
 
16. Mitä mieltä olette DR’s EXTRA tutkimusprojektin ensimmäisellä varsinaisella 
tutkimuskäynnillä Teille varatusta ajasta? 
 
Täysin riittämätön     1      2      3      4      5     Täysin riittävä      
 
17. Mitä mieltä olette tähän mennessä DR’s EXTRA tutkimusprojektista annetun tiedon 
määrästä?  
 
En ole saanut tietoa lainkaan     1      2      3      4      5     Olen saanut täysin riittävästi tietoa   
 
18. Mitä mieltä olette saamanne tiedon ymmärrettävyydestä?  
 
En ole ymmärtänyt lainkaan     1      2      3      4      5     Olen ymmärtänyt täysin 
 
19. Kuvailkaa omin sanoin, mikä on DR’s EXTRA tutkimusprojektin tarkoitus.  
 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
20. Kuinka paljon olette saanut tietoa perusteista, miksi Teidät valittiin 
tutkimushenkilöksi DR’s EXTRA tutkimusprojektiin? 
 
En ole saanut tietoa lainkaan     1      2      3      4      5     Olen saanut täysin riittävästi tietoa 
 
21. Kuinka paljon olette saanut tietoa DR’s EXTRA tutkimusprojektiin mahdollisesti 
liittyvistä haitoista? 
 
En ole saanut tietoa lainkaan     1      2      3      4      5     Olen saanut täysin riittävästi tietoa 
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22. Onko Teillä tiedossa oikeutenne keskeyttää tutkimus missä vaiheessa tahansa? 
 
1 Kyllä 
2 Ei 
 
23. Oletteko tähän mennessä harkinnut DR’s EXTRA tutkimusprojektin keskeyttämistä? 
 
1 Kyllä, miksi ________________________________________________________ 
2 En 
 
24. Kuinka paljon olette saanut tietoa DR’s EXTRA tutkimusprojektin rahoituksesta ja 
mahdollisista ”sponsoreista”? 
 
En ole saanut tietoa lainkaan     1      2      3      4      5     Olen saanut täysin riittävästi tietoa  
 
25. Kuinka paljon olette saanut tietoa tutkijoiden taloudellisista sidoksista DR’s EXTRA 
tutkimusprojektiin? 
 
En ole saanut tietoa lainkaan     1      2      3      4      5     Olen saanut täysin riittävästi tietoa 
 
Seuraava kysymys (26) koskee mielipidettänne tutkimusprojektien rahoitukseen liittyvästä 
tiedottamisesta, eikä koske vain DR’s EXTRA tutkimusprojektia. 
 
26. Kuinka tärkeänä koette tutkimusprojektin rahoitusta koskevan tiedon saamisen? 
 
En lainkaan tärkeänä     1      2      3      4      5    Erittäin tärkeänä  
 
27. Onko Teillä tietoa kuinka DR’s EXTRA tutkimusprojektista saadut tulokset on 
suunniteltu raportoitavan ja julkaistavan? 
 
1 Kyllä 
2 Ei 
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28. Olisitteko tarvinnut DR’s EXTRA tutkimusprojektiin liittyen joistakin asioista 
enemmän tietoa? 
 
1 Kyllä, mistä asioista _________________________________________________ 
2 En 
 
 
 III OSA: TUTKIMUSPROJEKTIIN OSALLISTUMISTA KOSKEVA PÄÄTÖKSENTEKO     
 
Seuraavat kaksi kysymystä (29–30) koskevat mielipidettänne eri tutkimusprojekteista, 
eivätkä tarkoita vain meneillään olevaa DR’s EXTRAa. Mikäli Te ette ole aikaisemmin ollut 
tutkimushenkilönä, vastatkaa DR’s EXTRA tutkimusprojektin perusteella. Teillä ei tarvitse 
olla omakohtaista kokemusta jokaisesta kysyttävästä asiasta, vaan niin sanottu mielikuva 
riittää. Täyttäkää jokainen kysyttävä kohta (1–9).  
 
29. Kuinka paljon seuraavat asiat voivat mielestänne vaikuttaa haluun osallistua 
tutkimusprojekteihin?  
Asteikko on samanlainen kuin aikaisemmissa kysymyksissä eli  
1=Kyseinen asia ei mielestäni vaikututa lainkaan haluun osallistua 
5=Kyseinen asia vaikuttaa mielestäni erittäin suuresti haluun osallistua. 
   
1 Halu auttaa muita 
2 Apua omaan sairauteen 
3 Läheisen henkilön sairaus 
4 Mahdollisuus päästä hoitoon/tutkimuksiin 
5 Halu miellyttää tutkimushenkilöstöä 
6 Pelko sairaalan henkilökunnan suuttumisesta 
7 Muut läheiset ovat osallistuneet 
8 Työpaikalla moni on osallistunut 
9 Muu vaikuttava asia, mikä 
______________________ 
1       2       3       4       5 
1       2       3       4       5 
1       2       3       4       5 
1       2       3       4       5 
1       2       3       4       5 
1       2       3       4       5 
1       2       3       4       5 
1       2       3       4       5 
 
1       2       3       4       5 
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30. Ympyröikää henkilöt, jotka voivat mielestänne vaikuttaa tutkimusprojekteihin 
osallistumista koskevaan päätöksentekoon. Voitte valita useamman vaihtoehdon. 
 
1 Tutkijalääkäri 
2 Tutkimushoitaja 
3 Muu tutkimusprojektiin kuuluva henkilö (esim. ravitsemusterapeutti) 
4 Lääkäri (muu kuin tutkimusprojektissa toimiva)  
5 Hoitaja (muu kuin tutkimusprojektissa toimiva) 
6 Osastonsihteeri / toimistotyöntekijä 
7 Omainen 
8 Tuttava 
9 Muu vaikuttava henkilö, kuka ___________________________________________ 
 
31. Oliko Teille mahdollisuus rauhassa harkita osallistumista DR’s EXTRA 
tutkimusprojektiin? 
 
1 Kyllä 
2 Ei 
 
32. Kuinka kauan harkitsitte osallistumistanne?  
 
__________________________________________________________________________ 
 
33. Millaiseksi koitte DR’s EXTRA tutkimusprojektiin osallistumista koskevan harkinta-
ajan riittävyyden? 
 
En saanut harkinta-aikaa lainkaan     1      2      3      4      5     Sain täysin riittävästi aikaa 
 
34. Keskustelitteko kenenkään ulkopuolisen (= ei tutkimuslaitoksen henkilökuntaan 
kuuluvan) henkilön kanssa DR’s EXTRA tutkimusprojektista ennen suostumustanne? 
 
1 Kyllä, kenen _______________________________________________________ 
2 En 
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35. Koetteko osallistuvanne DR’s EXTRA tutkimusprojektiin vapaasta tahdosta ja ilman 
painostusta? 
 
1 Kyllä 
2 En, miksi __________________________________________________________ 
 
36. Tunnetteko velvollisuudeksenne osallistua DR’s EXTRA tutkimusprojektiin? 
 
1 Kyllä, miksi ________________________________________________________ 
2 En 
 
37. Kuinka tutkimushenkilöstö varmisti tutkimuksen alussa, että olitte saanut riittävästi 
tietoa DR’s EXTRA tutkimusprojektiin liittyen?  
 
Tiedonsaantia ei varmistettu lainkaan     1      2      3      4      5     Täysin riittävästi 
 
38. Kuinka tutkimushenkilöstö varmisti tutkimuksen alussa, että olitte ymmärtänyt DR’s 
EXTRA tutkimusprojektista saamanne tiedon? 
 
Ymmärtämistä ei varmistettu lainkaan     1      2      3      4      5     Täysin riittävästi 
 
39. Suostumuksen antaminen DR’s EXTRA tutkimusprojektiin. 
 
1 Annoin suostumuksen suullisesti. 
2 Annoin suostumuksen kirjallisesti ennakkoon. 
3 Annoin suostumuksen kirjallisesti tutkimushenkilöstöön kuuluvan todistamana 
ensimmäisellä tapaamisella ennen tutkimusten alkua ja sain itselleni kopion, jossa 
on myös vastaanottajan allekirjoitus. 
4 Annoin suostumuksen kirjallisesti tutkimusten jo käynnistyttyä. 
5 Minulta ei kysytty varsinaisesti suostumusta, vaan saapumiseni tapaamiseen 
katsottiin ikään kuin myöntymiseksi. 
6 Muuten, miten ______________________________________________________ 
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40. Saatteko korvausta osallistumisestanne DR’s EXTRA tutkimusprojektiin? 
 
1 Kyllä 
2 En 
3 En tiedä 
 
Mikäli vastasitte edelliseen kysymykseen (40) kyllä, vastatkaa myös kysymyksiin 41–44. 
 
41. Mitä ja kuinka paljon saatte korvauksena? (esimerkiksi matkakulukorvaus, korvaus 
menetetystä työajasta, selvät rahakorvaukset, mainostuotteet jne.) 
 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
42. Mikäli saatte korvausta, niin tiedättekö kuka on maksaja? 
 
1 Kyllä 
2 En 
 
43. Mikäli saatte korvausta, niin tiesittekö siitä ennen kuin olitte tehneet DR’s EXTRA 
tutkimusprojektiin osallistumista koskevan päätöksen? 
 
1 Kyllä 
2 En 
 
44. Mikäli vastasitte edelliseen kysymykseen (43) kyllä, niin vaikuttiko tieto korvauksesta 
päätökseenne osallistua DR’s EXTRA tutkimusprojektiin? 
 
1 Kyllä, miten _______________________________________________________ 
2 Ei 
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